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 ABSTRACT 
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ABSTRACT 
 
Pyranonaphthoquinones are biologically important molecules found in a wide variety of 
bacteria, microbial fungi and plant species. Their biological activity is proposed to be a 
consequence of their ability to function as bioreductive alkylating agents. This class of 
compounds, which include monomeric and dimeric examples, contain the basic 
naphtho[2,3-c]pyran-5,10-dione skeleton, usually with substituents at the C-1 and C-3 
positions of the pyran ring. The aim of the first part of the project was to develop a novel 
method for the synthesis of enantiomerically pure 5,8-dimethoxy-isochroman-4-ol, which 
will provide a handle for stereoselectively adding substituents to the C-1 and C-3 
positions of the pyran nucleus. In the second part of the project we wished to attempt to 
synthesize the naturally occurring compound, cardinalin 3, the dimer of ventiloquinone L 
previously synthesized in the Wits laboratories. The synthesis of the enantiomerically 
pure isochromanol began with 2,5-dihydroxybenzoic acid, which was subjected to a 
diallylation followed by a Claisen rearrangement. The phenols were protected by a 
methylation reaction and the ester moiety was reduced to give (2-allyl-3,6-
dimethoxyphenyl)methanol. It was then allylated to produce a suitable precursor for a one 
pot/two step ruthenium mediated isomerisation/ring closing metathesis reaction to 
produce 5,8-dimethoxy-1H-isochromene in an overall yield of 47%. It was converted to 
racemic 5,8-dimethoxy-isochroman-4-ol through a hydroboration-oxidation reaction in a 
yield of 84%. The separation of the enantiomers was achieved by acetylating the alcohol 
to form 5,8-dimethoxy-3,4-dihydro-1H-isochromen-4-yl acetate and then a lipase enzyme 
was used to stereospecifically deacetylate one enantiomer, while leaving the other 
enantiomer untouched. The second part of the dissertation discusses the progress towards 
the synthesis of cardinalin 3. This project began with the formation of the C-C biaryl axis 
starting from 1,3-dimethoxybenzene. The synthesis then continued with the diformylation 
of the biphenyl to give 2,2’,6,6’-tetramethoxy[1,1′-biphenyl]-3,3′-dicarbaldehyde. This 
was subjected to a Stobbe condensation and a Friedel-Crafts acylative cyclisation to 
produce diethyl [4,4′-diacetoxy-6,6′,8,8′-tetramethoxy-7,7′-binaphthalene]-2,2′-
dicarboxylate. The synthesis will be continued in the PhD, using methodology previously 
developed for the formation of the monomer, as well as methodology developed here. 
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CHAPTER 1: INTRODUCTION AND AIMS 
 
1.1 Biologically Important Benzoisochromane Quinones 
 
Pyranonaphthoquinone antibiotics have been isolated from various strains of bacteria and 
fungi of microbial origin.1 They are typified by the presence of a basic naphtho[2,3-
c]pyran-5,10-dione skeleton 1 (Figure 1). Examples of this class of compounds include 
simple monomeric, dimeric and carbohydrate derived pyranonaphthoquinones. Also a 
common feature in many of these molecules is the presence of substituents in the C-1 and 
C-3 and sometimes in the C-4 position. In this dissertation, we will focus primarily on the 
monomeric and dimeric representatives of these biologically viable compounds and the 
next sections will describe some pertinent examples.  
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O
O
1
1
3
4
 
 
Figure 1 
 
1.1.1 Naturally Occurring Monomeric Quinones 
 
The pyranonaphthoquinone family of antibiotics display an extensive range of biological 
activity which include activity against a wide range of gram positive bacteria, pathogenic 
fungi and yeasts as well as antiviral activity.1 Simple examples of this are eleutherin 2 
and its C-3 epimer, isoeleutherin 3 (Figure 2). They were isolated from the tubers of 
Eleutherine bulbosa (Iradaceae).2 Eleutherin exhibits activity against Pycoccus aureus 
and Streptococcus haemolyticus A.3 
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Figure 2 
 
Thysanone 4 (Figure 2), a pyranonaphthoquinone isolated from Thysanophora 
penicilloides exhibits activity against the human rhinovirus 3C protease.4 It has thus 
provided a lead compound for the development of chemotherapeutic agents for the 
common cold.1  
 
The ventiloquinones are another series of closely related examples of monomeric 
pyranonaphthoquinone compounds, also with substituents in the C-1 and C-3 positions 
(Figure 3). Ventiloquinones A-E 5-9, were isolated5 from the acetone extracts of the root 
of the barks of two Indian plant species Ventilago maderaspatana and Ventilogo 
calcyculata while ventiloquinone L 10, was isolated from the root bark of Ventilago 
goughi.6  
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Figure 3 
 
The anti-fungal pigment kalafungin 11 (Figure 4), which was extracted from the 
fermentation broth of Streptomyces tanashiensis,7 was found to be inhibitory in vitro 
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against a variety of pathogenic fungi, protozoa, yeasts, gram-positive bacteria and some 
gram-negative bacteria.8 More recently, it was also found to be cytotoxic, displaying 
inhibitory activity against L5178Y mouse leukemic cells9 and to be an antithelmintic 
agent.10 This pyranoquinone contains an additional γ-lactone ring fused to the 
dihydropyran moiety and hence substituents at the C-1, C-3 and C-4 positions. 
Nanaomycin D 12, (Figure 4) isolated from Streptomyces rosa, was found to be the 
enantiomer to kalafungin, and to possess almost identical antibacterial properties.11  
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Also structurally similar to kalafungin, are the frenolicins, isolated12 from Streptomyces 
fradiae (Figure 5). Frenolicin B 13, contains a propyl side chain at C-1, instead of the 
usual methyl group. Frenolicin 14, and it’s reduced form, deoxyfrenolicin 15, also have 
the propyl side chain as well as a carboxylic acid side chain at C-3, as a result of the ring 
opening of the γ-lactone.  
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Figure 5 
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While frenolicin 14, shows only weak antibacterial activity13, deoxyfrenolicin 15, 
possesses significant in vitro activity against a variety of fungi14 and frenolicin B 13, 
strongly inhibits platelet aggregation.15 Other novel kalafungin-type antibiotics were 
isolated from the fermentation broth of Actinoplanes arizonaenis. Arizonin A1 16, and 
arizonin B1 17, (Figure 6) both exhibit moderate activity against pathogenic strains of 
gram-positive bacteria16 as does griseusin 18, isolated from the cultures of Streptomyces 
griseus K-63.17 Griseusin 18 is one of the more complex members of the 
pyranonaphthoquinone family. It contains a 1,7 dioxaspiro[5,5]undecane ring system 
fused to a juglone moiety. 
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1.1.2 Naturally Occurring Dimeric Quinones 
 
The first example in this section comes from a series of dimeric pigments from 
Streptomyces coelicolor known as the actinorhodins. Actinorhodin 19, (Figure 7) 
contains a C8-C8′ biaryl linkage with the two halves exhibiting identical stereochemical 
features, whereas in δ-actinorhodin 20 there is a six-membered lactone supplementing the 
connection between the two halves as well as two γ-lactams. There has been reported 
activity of 19 against Staphalococcus aureus.18  
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Figure 7 
 
The major biologically active component of an antibiotic complex produced by a 
microorganism Micromonospora purpureochromogenes sub-species halotolerans, 
crisamycin A 21, displays excellent activity against gram-positive bacteria, and has also 
exhibited in vitro activity against B16 murine melanoma cells, herpes simplex virus and 
vesicular stomatitis virus.19 Also isolated from these extracts was crisamycin C 22, the 
epoxide derivative of 21. It exhibits the same range of activity as 21 but is much more 
potent. 
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Figure 8 
 
Another class of dimers, the cardinalins, were the first class of pyranonaphthoquinones to 
be isolated from higher order fungi.20 They were isolated  from the ethanol extracts of the 
toad stool Dermocybe cardinalis. The deep red ethanolic extracts showed significant 
cytotoxic activity (IC50 of 0.47 µg cm-3) against a P388 murine leukemia cell line.20 The 
individual components of the mixture were then separately examined. Some examples are 
given below in Figure 9. The symmetrical dimer cardinalin 3 23 contains only the C8-
C8′ biaryl linkage, with a bis-naphthoquinone skeleton, while cardinalin 4 24 and its C-
4a′ epimer cardinalin 5 25, have an ether linkage supplementing this linkage. Cardinalin 3 
23 shows no asymmetric doubling in either the 1H or 13C NMR spectra, and can therefore 
be assumed to occur as discrete atropisomers.20 Comparison of the circular dichromism 
(CD) spectra of 23 with binaphthyls where the stereochemistry of the biaryl linkage is 
known, has shown that cardinalin 3 23 possesses (S) chirality at the stereogenic axis.20 
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Figure 9 
 
These monomeric and dimeric pyranonaphthoquinones are just a few representative 
examples of an extensive range of naturally occurring, biologically active molecules. 
Their biological activities are thought to be a consequence of their interesting chemical 
structures. While there are many proposed mechanisms of antineoplastic action, we will 
focus on the model of the bioactivation of quinones to produce quinone methides, which 
are proposed to behave as alkylating agents,21,22 selectively forming covalent bonds with 
the DNA of cancer cells, resulting in the anticancer activity of the quinone. 
 
1.2 Bioreductive Alkylating Agents 
 
The term “bioreductive alkylation” was introduced by Lin.23 This hypothesis was used to 
explain the biological activity of the pyranonaphthoquinones and to predict their 
important structural features. The idea behind bioactivation lies in the fact that a drug is 
introduced as a biologically inactive form, and only after in vivo activation is it able to 
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carry out its function. In the case of quinones e.g. 26, in vivo bioreduction results in the 
hydroquinone 27. The cleavage of a benzylic substituent from 27, by the mesomerically 
assisted loss of HX results in the formation of a quinone methide 28. The quinone 
methide can now form covalent adducts such as 29 with biological nucleophiles such as 
DNA, proteins or carbohydrates through a Michael addition to the reactive enone system 
of 28. The formation of the covalent adduct with DNA for example, renders it incapable 
of carrying out its normal function, thus leading to cell death. Once this cytotoxic activity 
of the quinone has been carried out, the adduct can be oxidized, resulting in its 
biologically inactive form 30.24 This is depicted in Scheme 1. 
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R
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O
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R
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R
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2H
2e
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-HX
 
 
Scheme 1 
 
The process depicted in Scheme 1 will be discussed below, with specific examples; 
however they are general for many biologically active quinones. 
 
1.2.1 In vivo Bioreduction 
 
An example of a compound which requires bioactivation to achieve biological activity is 
the antibiotic mitomycin C 31 (Figure 10), a potent inhibitor of transplantable rodent 
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tumours. The compound is believed to function as an antitumour alkylating agent. It has 
been found that the anticancer agent 31, which contains the quinone functionality, is 
inactive in aerobic conditions, and requires bioreduction to the hydroquinone for 
biological activity.25,26 
 
H2N
Me N NH
CH2OCONH2
OCH3
O
O
31  
 
Figure 10 
 
It was further shown by Iyer and Szybalsky that an NADPH-dependant reductase system 
was involved in this step.26 NADPH is the reduced form of nicotinamide adenine 
dinucleotide phosphate, and is a non-specific electron donor. Several chemical, 
electrochemical and enzymatic methods have been used to bring about in vitro reductive 
activation. Koch and co-workers27 described the reduction of daunomycin 32, an 
anthracycline antitumour drug, containing a quinone moiety, using sodium dithionite in 
DMSO, to form the quinone methide 34. (Scheme 2) They were also able to effect the 
reduction with 3,5,5-trimethyl-2-oxomorpholin-3-yl (TM-3) 33 and sodium borohydride. 
When using TM-3 33, a one electron donor, one equivalent of the reducing agent first 
produced a semiquinone and a second equivalent produces the 7-deoxydaunomycin 34. In 
the case of the NaBH4, the reaction proceeded through a hydroquinone borate followed 
by a quinone methide borate. In all cases reduction was found to take place preferentially 
under anaerobic conditions. 
 
CHAPTER 1 INTRODUCTION AND AIMS 
10 
O
OH
O
OOMe OH
OH O
O
OH
NH2
32
OH
OH
OOMe OH
OH O
34
Na2S2O4, DMSO
or 2 equiv.
N
O O
H33
 
 
Scheme 2 
 
For the successful treatment of cancerous tumours using chemotherapy it is essential for 
the drug to be able to differentiate between the host and target cells. This property of 
bioactivation under anaerobic conditions is an extremely beneficial property as it is 
possible to make the potential drug selective between host and target cells. The reason for 
this is that solid tumours have regions of poor vascularity due to their extremely rapid 
growth and hypoxic (oxygen deficient) cells may exist at the centre, remote from 
surrounding blood vessels.28 This population of hypoxic cells allows the possibility of 
designing drugs that are capable of bioactivation in a hypoxic environment. As quinones 
are activated by a reductive mechanism, their potential for development as hypoxia 
selective cytotoxins is plausible28 thus leaving analogous and healthy oxygen-rich cells 
unaffected. 
 
1.2.2 Formation of Quinone Methides 
 
Bioreductive alkylating agents can be classified according to the mechanism of formation 
of their quinone methides. Some simple models have been postulated and are described 
below. 
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1.2.2.1 Quinone Methide Formation by Bioreduction and Elimination 
 
This model was proposed by Lin et al.23 to explain the neoplastic activity of simple 
quinones containing one or more –CH2-X substituents, where X is a leaving group 
(Scheme 3), e.g. 35 (with X = OCOCH3). The elimination of HX to produce the quinone 
methide 37 can be enhanced when there are electron-releasing substituents on the ring, 
however the reduction to the hydroquinone 36 is then more sluggish. These quinones do 
however show enhanced biological activity when compared to those substituted with 
electron-withdrawing groups.24  
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H
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O
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Nu
38
Nu
O
O
O
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Scheme 3 
 
The quinone methide can then undergo nucleophilic addition to form a covalently bonded 
adduct 38 to for example a cancer cell, inhibiting further activity and thus resulting in cell 
death.  
 
1.2.2.2 Vinylogous Quinone Methides 
 
This is a variation of the above mechanism, where the leaving group is substituted with 
an alkenyl group as in compound 39. Reduction to the hydroquinone 40 and subsequent 
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loss of HX results in the vinylogous quinone methide 41, which can then function as an 
alkylating agent by Michael addition of the biological nucleophile to form compound 42 
(Scheme 4). 
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Scheme 4 
 
1.2.2.3 Bis-alkylating Agents 
 
Several quinones are capable of producing two alkylating sites, which tend to be arranged 
in a 1,4-cisoid dienyl arrangement as in structure 43 (Figure 11). 
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Figure 11 
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An example of this type of bis-alkylating agent can be produced from the fused pyrano-γ-
lactone quinone, kalafungin 11. Reduction of the naturally occurring compound 11 to the 
hydroquinone 44, followed by molecular rearrangement and opening of the γ-lactone ring 
produces the quinone methide 45, which may function as an alkylating agent. Further 
elimination of 45 could then result in the bis-quinone methide 46 (Scheme 5).28 
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Scheme 5 
 
1.2.3 Addition of Biological Nucleophiles to Quinone Methides 
 
The mode of action of quinones at the DNA level still remains a topic of speculation and 
debate. Phillips and co-workers detected in vitro covalent adducts between adriamycin 47 
(Figure 12) and DNA.29 Their experimental evidence pointed to interstrand cross-links in 
the DNA which were found to contain the adriamycin chromaphore. The binding to this 
biologically important nucleophilic target would account for the inhibition of the template 
action of DNA, thus blocking the synthesis of DNA, RNA and proteins and leading to 
chromosomal abnormalities in cells exposed to these alkylating agents. 
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Figure 12 
 
There has been much research carried out on the in vitro nucleophilic addition to quinone 
methides.30-32 Koch and co-workers found that the treatment of the quinone methide 48 of 
andriamycin 47 with reduced glutathione 49 led to the glutathione conjugate 50. (Scheme 
6).30 The same group also reported the addition of N-acetylcysteine 51 to the quinone 
methide 34 of daunomycin 32 to form the quinone adduct 52 (Scheme 7). Angle et al. 
showed that treatment of a quinone methide 53 with various nucleophiles led to the 
formation of conjugate addition adducts 53a-f.32 This is shown in Scheme 8 with the list 
of nucleophiles. 
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Scheme 8 
 
Once the formation of the covalent bond with the nucleophile has taken place the 
hydroquinone adduct can then be oxidized to the quinone. This adduct is now 
biologically inactive. 
 
1.3 Biosynthesis 
 
Benzoisochromane quinones are essentially polyketides and their biosynthesis involves a 
series of decarboxylative condensation reactions between small carboxylic acids and 
malonate using enzyme complexes. The highly reactive intermediate produced is then 
further processed through a set of intramolecular cyclisation, elimination, redox and 
group transfer reactions to generate the highly functionalized natural product.33 The 
biosynthetic mechanism of Streptomyces pyranonaphthoquinone antibiotics is proposed 
to follow a polyketide pathway, similar to fatty acid biosynthesis in which the carbon 
backbone arises from the condensation of acetate units derived from acetyl-CoA or 
malonyl-CoA.33-36 The cyclisation of the polyketide intermediates is achieved through 
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intermolecular aldol condensations. The biosynthesis of actinorhodin 19 is shown in 
Scheme 9.37 
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Scheme 9 
 
According to a study on the cyclisation pattern of synthetic oligoketides,33 the polyketide 
derived from an acetyl CoA starter unit and seven malonyl CoA extender units undergoes 
transformation through a regiospecific intramolecular aldol condensation between C-7 
and C-12. A second aldolase then forms the bond between C-5 and C-14. It then 
undergoes aromatisation of the two rings, oxidation to the quinone, hydroxylation and 
dimerisation to form actinorhodin 19. The genes present in the biosynthetic pathway are 
denoted by ‘act’ in Scheme 9. 
 
1.4 Synthetic Strategies Towards Benzoisochromane Quinones 
 
Due to their significant biological activity as well as their interesting and challenging 
structures, benzoisochromane quinones have received much attention from synthetic 
chemists. Numerous synthetic methods have been developed and in this chapter some of 
the different approaches towards their synthesis will be presented. 
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1.4.1 Syntheses of the Monomeric Benzoisochromane Quinones 
 
1.4.1.1 Biomimetic Approaches 
 
Since much chemical effort has been devoted towards the study of the biosynthesis of 
polyketide chains, one approach towards the chemical synthesis of benzoisochromane 
quinones was to mimic the strategy adopted by nature.38 (±)-Eleutherin 2 and 
isoeleutherin 3 were synthesized in a biomimetic fashion starting from 2-
pyrrolidinylgluterate diester 56 as shown in Scheme 10.39 Tandem attack of two 
equivalents of the dianion of acetylacetone 55 on ester 56 produced the heptaketide 57, 
which underwent a spontaneous cyclisation to form the naphthyl diketone 58. This was 
then treated with trifluoroacetic acid to accomplish the cyclisation of the third ring 
producing the pyran 59. Catalytic hydrogenation followed by monomethylation, in the 
absence of light, produced a 9:1 mixture of cis and trans pyrans 60 and 61. The mixture 
of isomers was then oxidized with Fremys salt to afford the quinones 2 and 3. While the 
major cis isomer was assigned as (±)-eleutherin 2, isomerisation of 2 in phosphoric acid 
afforded an equilibrium mixture with mainly the trans isomer 3. 
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Scheme 10 Reagents and conditions: (i) 55, LDA, THF, -78 °C, then 56, -35 °C; (ii) EtOH, 
CF3CO2H cat., reflux; (iii) 5% Pd/C, EtOH, H2, rt; (iv) CH2N2, Et2O; (v) (KSO3)2NO; (vi) H3PO4. 
 
1.4.1.2 Phthalide Annulations 
 
The use of phenylsulphonyl phthalides has been a common method to construct several 
pyranonaphthoquinone antibiotics.40 This approach was used by Tatsuta et al.41 in the 
synthesis of the nanaomycins and kalafungins. (Scheme 11). The addition of the lithium 
tert-butoxide generated anion of 62 to the Michael acceptor 63 and gave an intermediate 
bridged structure which was then transformed to the hydroquinone 64 via concomitant 
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cleavage of the γ-lactone and loss of the phenylsulfonyl group followed by tautomerism. 
The free phenols of 64 were then protected as methyl ethers and the product was 
subjected to sodium borohydride reduction to yield 65 exclusively in the 3,4-syn 
configuration. 
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Scheme 11 Reagents and conditions: (i) t-BuOLi, THF, 80%; (ii) K2CO3, (MeO)2SO2, acetone, 
40 °C; (iii) NaBH4, MeOH, 88%. 
 
1.4.1.3 Reductive Mercury(II) Acetate-Mediated Cyclisations 
 
It has been demonstrated by de Koning and co-workers42 that the oxidative ring closure 
of benzylic alcohol 66 with mercury(II) acetate, and other subsequent steps affords the 
isochromanol 69 (Scheme 12). Their syntheses relies on the fact that a vinyl substituent is 
present ortho to the benzyl alcohol. The isochromanol 69 was synthesized by first 
treating 66 with mercury(II) acetate followed by treatment of the resultant mercury(II) 
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intermediate with oxygen, and then sodium borohydride, to yield a 1:1 mixture of the 
cis:trans alcohols 67. This alcohol was then oxidized to the corresponding ketone 68 and 
subsequently reduced to afford only the cis-isochroman-4-ol 69. 
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Scheme 12 Reagents and conditions: (i) Hg(OAc)2, THF, 15 min; (ii) NaBH4, DMF, O2, 86%; 
(iii) PCC, CH2Cl2, 74%; (iv) LiAlH4, Et2O, 80%. 
 
1.4.1.4 Ring Expansions of Substituted Cyclobutanones 
 
Moore and co-workers43 have proposed a different approach to the synthesis of a quinone 
nucleus. They have presented a general enantioselective route to lactones such as 75. The 
key reaction involved the electrocyclic ring opening of the cyclobutanone to a conjugated 
ketene, which then underwent thermal ring closure and rearrangement to form quinones 
or hydroquinones. In the example depicted in Scheme 13, treatment of cyclobutanedione 
70 with lithiated lactol 71 in ether at −78 °C gave 72 in a 51% yield. Upon thermolysis of 
this compound in refluxing toluene, 72 was converted into the ketene intermediate 73. 
This was followed by a pericyclic rearrangement to result in a ring expanded 
intermediate, which tautomerised to the isochromane 74. Treatment of 74 with HCl 
followed by pyridinium chlorochromate (PCC) oxidation then yielded the quinone 
lactone 75 in an overall yield of 38%. 
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Scheme 13 Reagents and conditions: (i) Et2O, -78 °C; (ii) 110 °C; (iii) HCl; (iv) PCC. 
 
1.4.2 Synthesis of Dimeric Benzoisochromane Quinones 
 
The synthesis of dimeric benzoisochromane quinones from closely related naturally 
occurring metabolites is an approach that has proved particularly useful. The monomer 
units of dimeric compounds can also be synthesised however the penultimate coupling 
step is sometimes not achieved. Consequently these compounds are normally made from 
pre-existing molecules that carry the required functionality, or by mimicking the process 
by which they are formed naturally.40 Some examples of this will be depicted in the next 
section. 
 
1.4.2.1 Synthesis from other Natural Products 
 
In the synthesis of the enantiomer of actinorhodin 80 by Laatsch44 (Scheme 14) 
cyclisation, methylation and deacetylation of α-naphthocyclinone 76 produced 
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deacetylanhydro-α-naphthocyclinone methyl ester 77, which was then degraded by 
diazomethane to form naphthol 78 after monomethylation. Oxidative coupling of this 
monomer 78 then provided the dimer 79, which was oxidized with cerium(IV) nitrate to 
afford the dimer 80, the enantiomer of actinorhodin (19). 
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Scheme 14 Reagents and conditions: (i) CH2N2, CH2Cl2, 0 °C; (ii) Ag2O, Et3N, CHCl3; (iii) aq. 
CAN, MeCN. 
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1.4.2.2 Coupling of Monomer Units 
 
The biosynthetic formation of the protoaphin 83 and protoaphin-fb 84 in vivo is likely to 
involve the coupling between the two halves of the molecules. This coupling has been 
achieved in vitro45 by the heating of quinone A 81 and glucoside B 82 (Scheme 15). In 
this case the glucoside is thought to be utilized as an electron donor and the quinone as 
the electron acceptor. Self rather than mixed coupling has also been carried out with 81 
and 82.46  
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Scheme 15 Reagents and conditions: (i) pH 6.6, aq. solution, 80 °C. 
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1.5 Aims of this Project 
 
The aims of this project have been divided into two sections. Firstly we will aim to 
develop a novel method for the synthesis of enantiomerically pure isochromanols 85a and 
85b. These molecules will provide us with a handle for stereoselectively adding 
substituents to the C-1 and C-3 positions, as found in many naturally occurring 
pyranonaphthoquinones. With these methods in place, for the second part of this project, 
we hope to develop synthetic procedures for the synthesis of the naturally occurring 
cardinalin 3 23. (Figure 13). 
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Figure 13 
 
1.5.1 Synthesis of Enantiomerically Pure Isochromanols 
 
The racemic alcohol 85 can be disconnected, through a hydroboration-oxidation reaction 
(Section 2.1.2) back to the isochromene 86, which we plan to synthesize using ring 
closing metathesis (RCM) (discussed in Section 2.1.1). The precursor for this novel step 
is the diallyl ether 87 which disconnects back to the benzyl alcohol 88, which has been 
previously synthesised at the Wits laboratories.47 The retrosynthesis is presented in 
Scheme 16. 
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Scheme 16 
 
With the racemic alcohol 85 in hand, it should be possible to separate the two 
enantiomers, using an enantioselective enzymatic reaction. In order to achieve this, the 
alcohol 85 will be acetylated to form 89. A lipase enzyme will then used to de-acetylated 
one enantiomer of 89 while leaving the other enantiomer untouched (Scheme 17). This 
work is discussed in Section 2.1.3. 
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Scheme 17 
 
CHAPTER 1 INTRODUCTION AND AIMS 
27 
Finally, the need for enantiomerically pure alcohols 85a and 85b in order to add the 
required methyl groups to positions C-1 and C-3, in a stereoselective manner will be 
discussed in Chapter 3. 
 
1.5.2 Progress Towards the Synthesis of Cardinalin 3 
 
Previously in our laboratories, the synthesis of the naturally occurring ventiloquinone L 
10 was successfully carried out starting from 2,4-dimethoxybenzaldehyde 90 (Scheme 18 
and 19).48,49 The readily available starting material 90 was subjected to a Stobbe 
condensation with diethyl succinate, followed by Friedel-Crafts acylative cyclisation to 
produce the acetoxynaphthalenecarboxylic acid ethyl ester 91. Chemoselective phenolic 
acetate hydrolysis with guanidine produced the naphthol 92. This product was then 
subjected to routine allylation to give the ether 93, which then underwent thermal Claisen 
rearrangement to yield 94. The phenol was then protected as the benzyl ether 95 by O-
benzylation. The aldehyde 97 was produced over two steps, by initially reducing the ester 
to the primary alcohol 96, followed by partial re-oxidation with pyridium 
chlorochromate.  
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Scheme 18 Reagents and conditions: (i) (a) Diethyl succinate, tBuOH, KOtBu, reflux, 2 h; then 
(b) NaOAc, Ac2O, 140 °C, 2 h, 77%; (ii) guanidine, EtOH, CH2Cl2, rt, 1 h, 95%; (iii) K2CO3, 
allyl bromide, acetone, reflux, 16 h, 99%; (iv) DMF, 170 °C, 12 h, 75%; (v) K2CO3, BnCl, KI, 
acetone, reflux, 18 h, 100%; (vi) LiAlH4, THF, 0 °C→rt, 18 h, 95%; (vii) PCC-Al2O3, CH2Cl2, rt, 
8 h, 78%. 
 
Treatment of the aldehyde 97 with methylmagnesium iodide gave the desired alcohol 98. 
This alcohol 98 was subjected to Wacker oxidation to produce to isochromene 99. 
Catalytic hydrogenation of 99 over palladium on charcoal resulted in reduction of the 
enol ether as well as hydrogenolysis of the benzyl group in the one step to give 
predominately the cis isochromanol 100. Pure rac-cis 100 was dissolved in DMF and 
treated with oxygen gas under salcomine catalysis to give the desired quinone; the 
literature reported 7-methoxyeleutherin 101. Selective cleavage of the C-8 methyl ether 
with boron trichloride gave the desired target rac-ventiloquinone L 10. 
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Scheme 19 Reagents and conditions: (i) MeMgI, Et2O, THF, 0 °C→rt, 18 h, 95%; (ii) 
PdCl2(cat), CuCl2, H2O, DMF, O2, rt, 3 h, 92%; (iii) Pd-C(cat), H2(500 kPa), CH2Cl2, dioxane, rt, 
48 h, 45% (for 3:1 cis:trans mixture); (iv) Salcomine(cat), DMF, O2, rt, 18 h, 90%; (v) BCl3, 
CH2Cl2, -78 °C, 70%. 
 
Ventiloquinone L 10 is the monomer of the naturally occurring cardinalin 3 23. On 
completion of the synthesis of 10, numerous methods were employed to attempt 
“dimerising” the molecule to give 23, however they were all unsuccessful. In this project, 
we hoped to make progress towards the synthesis of 23 using this overall synthetic 
methodology but with different tactics. Therefore in our synthesis we commence with the 
formation of the final C8-C8′ biaryl axis of 23 as a first step and then continue with the 
planned synthesis in a bi-directional manner. The retrosynthesis of cardinalin 3 23 
(Scheme 20), following the developed methodology disconnects to the bis-
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acetoxynaphthalenecarboxylic acid ethyl ester 105, which is derived from the Stobbe 
condensation of the diformylated biphenyl 104. This molecule can be further 
disconnected to the tetramethoxy biphenyl 103 which is synthesised from the 
homocoupling of commercially available 1,3 dimethoxybenzene 102. 
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Scheme 20 
 
Although the complete synthesis was not achieved in this project, we believe that the 
final steps for formation of the pyran ring of cardinalin 3 23, can be achieved utilising 
enzymes as well as arene chromium tricarbonyl complexes (discussed in Chapter 3) for 
the stereoselective addition of the C-1 and C-3 methyl substituents. 
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CHAPTER 2: RESULTS AND DISCUSSION: PART A 
 
2.1 Synthesis of the Allyl Ether 87 
 
Using well documented methodology, the synthesis of the diallyl ether 87 could be easily 
achieved from commercially available 2,5-dihydroxybenzoic acid 106. The retrosynthesis 
of our synthetic strategy is shown below in Scheme 21. The allyl ether 87 could be 
disconnected to the benzyl alcohol 88 through a retro O-allylation. The benzyl alcohol 88 
was disconnected to the ether 109. It could be obtained from the reduction of the ester 
moiety of 109. The ether 109 was disconnected to the unprotected 108 through a retro-
methylation. The C-allylated 108 was a result of a regioselective Claisen rearrangement 
of 107. Finally 107 was disconnected to the readily available 106 through a double O-
allylation. 
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Scheme 21 
 
Our synthesis began with the treatment of 2,5-dihydroxybenzoic acid 106, in a 1 molal 
solution in acetone, with 2.2 equivalents each of potassium carbonate and allyl bromide, 
under reflux conditions (Scheme 22). These dilute conditions were found to be optimal 
for the synthesis of the desired diallylated product 107. The carboxylic acid proton should 
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be the most acidic proton, with a pKa of approximately 5 and hence allyl ester formation 
should be completed first. The phenolic protons have a pKa of about 10. The phenol ortho 
to the acid, however, is not only more sterically crowded, but is also expected to display 
hydrogen bonding, being in close proximity to the carbonyl, thus hindering the formation 
of the 2-allyl ether. The desired compound 107 was obtained in a yield of 92%. 
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Scheme 22 Reagents and conditions: (i) K2CO3, allyl bromide, acetone, ∆, 24 h, 92%. 
 
A prominent singlet at δ 10.35 in the 1H NMR spectrum of 107, was clear evidence of the 
hydrogen-bonded 2-hydroxy group. The desired diallylated species, also revealed the 
typical splitting pattern in the aromatic region consistent with a 1,2,4-aromatic 
trisubstitution pattern. The doublet furthest downfield was assigned to 6-H, as it is the 
most deshielded aromatic proton due to the electron withdrawing effects of the carbonyl 
group as well as the anisotropic effects of the carboxylate group. The doublet clearly 
showed meta coupling to 4-H with J=3.1 Hz. The doublet of doublets, assigned to 4-H, 
showed ortho and meta coupling to 3-H and 6-H respectively, with coupling constants of 
J=9.1 and 3.1 Hz respectively. It is expected further downfield than 3-H due to the 
electron withdrawing mesomeric effect of the carboxylate at the para position. The signal 
for 3-H showed only ortho coupling to 4-H with J=9.1 Hz. It was most upfield, being the 
most strongly influenced by the shielding effect of the electron donating ortho phenol 
substituent of 107. The ether and ester methylene protons were observed as two doublets 
at δ 4.50 and δ 4.85 with coupling constants of J=5.3 and 5.7 Hz respectively. 
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Claisen rearrangement of the diallylated compound was then achieved by heating the 
compound in the absence of solvent at 170 °C for 24 hours. Although there are two ortho  
positions available (C-6 and C-4) for the pericyclic [3,3] sigmatropic shift, at completion 
of the reaction there was only a single product, shown by TLC analysis. This was 
confirmed to be the desired, more sterically hindered hydroquinone 108 in an 86% yield. 
It has previously been shown50,51 that electron-withdrawing substituents, in this case an 
ester, favour Claisen-migration to the position ortho to them. It has further been 
suggested that strong internal hydrogen bonding as shown in 107, confers a 
naphthalenoid character on the molecule.50 The arrangement resembles that of 2-
allyloxynaphthalene 110, which gives 1-allyl-2-naphthol 111 exclusively on Claisen 
rearrangement (Scheme 23). 
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Scheme 23 Reagents and conditions (i) 170 °C, 24 h. 
 
The rearrangement of the allyl substituent ortho to the ester was unequivocally confirmed 
by the NMR spectroscopic data. The aromatic region of the 1H NMR spectrum was 
simplified by the disappearance of the doublet at δ 7.36 for the 6-H of 107. Instead it now 
contained only 2 doublets, integrating for 1 proton each, at δ 6.99 and δ 6.82, showing a 
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typical ortho relationship with coupling constants of J=8.9 Hz. Further confirmation that 
the O-allyl group was now a C-allyl substituent was evident in the upfield shift of the 
allyl methylene carbon signal from δ 69.6 to δ 32.4 in the 13C NMR spectrum. All other 
signals in both the 1H and 13C NMR spectra were in line with expectations. 
 
The free hydroquinone 108 was then protected as its bis(methyl)ether 109, by treatment 
of 108 with potassium carbonate and dimethyl sulfate, in acetone, under reflux 
conditions. The yellow mixture initially turned purple-brown, indicative of the phenoxide 
formation. It finally became light brown in colour when the methylation was complete. 
Analysis by TLC showed a characteristic purple spot corresponding to the protected 
hydroquinone 109 (Figure 14). The excess dimethylsulfate was quenched by the addition 
of an aqueous ammonia solution and finally purified by column chromatography to 
produce 109 in an 82% yield. The disappearance of the phenolic signals was 
complemented by two new singlets at δ 3.78 and δ 3.77, integrating for 3 protons each, 
indicating the presence of the two methoxy groups. Methylation was further confirmed 
by the disappearance of the O-H stretch at 3424 cm-1 in the IR spectrum of 109. 
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Figure 14 
 
The ester 109, was then subjected to reduction by lithium aluminium hydride in THF to 
afford the alcohol 88 in 93% yield (Figure 15). The signals for the allylic ester protons 
were no longer present in the 1H NMR spectrum of 88. A new singlet at δ 4.71 was 
assigned to the benzylic protons on the hydroxyl-bearing carbon. A broad signal at δ 2.30 
was characteristic of the proton of the alcohol group. This was further confirmed by a 
broad IR spectral band at 3416 cm-1 for the hydroxyl O-H stretch. The 13C NMR 
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spectrum of the starting material 109, showed a signal for an ester at δ 167.4, was no 
longer present in the 13C NMR spectrum for the alcohol 88. Instead a signal for the 
benzylic carbon was evident at δ 55.8. 
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Figure 15 
 
O-Allylation of the alcohol 88 was smoothly achieved by stirring a THF solution of 88 in 
the presence of sodium hydride and allyl bromide at reflux for 24 hours. TLC analysis of 
the reaction mixture showed a single spot with Rf = 0.59, as opposed to the much lower Rf 
= 0.32 for the alcohol with a 20% EtOAc/hexane eluent. The oil contaminant from the 
sodium hydride reagent was removed by gradually increasing the eluent polarity from 
hexane to 20% EtOAc/hexane on a silica gel column. The formation of 87 was confirmed 
by the absence of the benzylic hydroxy proton signal in its 1H NMR spectrum, as well as 
the additional signals at δ 6.03-5.89, 5.32-5.16 and 4.03 clearly showing that an O-allyl 
substituent was attached to the benzylic alcohol (Figure 16). 
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Figure 16 
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With the allyl ether 87 in hand, we are now ready to form our model isochromene system 
86, utilising RCM with the Grubbs second generation ruthenium catalyst as well as 
ruthenium mediated isomerisation as shown in the retrosynthesis in Scheme 24. 
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Scheme 24 
 
2.1.1 The Synthesis of Benzo-Fused Isochromene Systems 
 
As previously described, numerous other methods have been developed in forming 
isochromene systems. Our aim was to synthesise our desired isochromene 86, by utilizing 
the metal catalyzed transformation known as ring closing metathesis (RCM). 
 
2.1.1.1 Oxygen Heterocycle Formation by Ring Closing Metathesis 
 
The fundamental discovery that the in situ generation of catalysts from certain transition 
metal salts and main group alkylating agents, not only promote polymerisation of olefins, 
but can also effect the mutual alkylidene exchange reaction of alkenes, has evolved into a 
highly prosperous field of research.52 This transformation was awarded the Nobel Prize in 
Chemistry to Grubbs, Shrock and Chauvin in 2005. It involves the cleavage and 
formation of double bonds, as depicted in Scheme 25, and has become a popular method 
for the assembly of cyclic alkenes.52 This synthetic approach is generally referred to as 
“alkene metathesis”. 
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Scheme 25 
 
Extensive research in the field of organometallic chemistry has lead to the discovery of a 
new generation of metal alkylidene complexes, which have proved to be reasonably 
oxygen and moisture tolerant, thermally stable, high performing catalysts.53 Among the 
most popular and versatile catalysts, are the ruthenium carbene complexes such as 113 
(Figure 17), introduced by Grubbs and co-workers,54 which have become well embraced 
tools for advanced organic synthesis. 
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Figure 17 
 
The generally accepted mechanism of metathesis reactions, as proposed by Chauvin55 
consists of a sequence of formal [2+2] cycloadditions/cycloreversions involving alkenes, 
metal carbenes and metallocyclobutane intermediates. A generalised catalytic cycle, 
involving a Grubbs-type metathesis catalyst (with ruthenium being the metal), is shown 
in Scheme 26. 
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Scheme 26 
 
Although the individual steps leading to the overall transformation are reversible, the 
equilibrium is often directed by thermodynamic effects.52 If, as shown in the general 
cycle, one of the olefin products of the reaction is volatile (ethene), the desired 
cycloalkene will accumulate in the reaction mixture. 
 
Examination of our model isochromene 86, shows that it could be possible to assemble 
this product using the RCM reaction as shown in the retrosynthesis below (Scheme 27). 
The target compound must however be made from the conjugated alkene 112. Therefore 
as the first step we needed to make 112 from 87 before attempting the RCM reaction. 
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Scheme 27 
 
2.1.1.2 Ruthenium-Mediated Isomerisation 
 
Previously, in our laboratories, various methods for the isomerisation of terminal alkenes 
to internal alkenes have been attempted.47 Initially, using methodology demonstrated by 
de Koning and co-workers42 selective conversion of the C-allylic group was achieved, 
while preserving the O-allylic functionality 114. This would afford a seven-membered 
heterocycle starting from the precursor 87. However 114 failed to undergo the desired 
RCM to yield 115. (Scheme 28) 
 
OMe
OMe
O
87
OMe
OMe
O
114
O
OMe
OMe
115
(i) (ii)
 
 
Scheme 28 Reagents and conditions: (i) KOtBu, DMF, rt, 16 h, 81%47; (ii) toluene, Grubbs II 
cat. 113, 70 °C, 24 h. 
 
Another method attempted, was the synthesis of a vinyl ether, using the catalytic method 
developed by Ishii and co-workers56 (Scheme 29). Benzyl alcohol 116 was heated in 
toluene at reflux with vinyl acetate and either sodium acetate or sodium carbonate as the 
base, in the presence of the iridium catalyst, bis(cyclooctadienyliridium (II) chloride) for 
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ten hours to afford 117.47 This methodology however, proved fruitless for the conversion 
of 88 to the corresponding vinyl ether 108. 
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Scheme 29 Reagents and conditions: (i) [Ir(cod)Cl2]2, Na2CO3, toluene, 100 °C, 94%. 
 
Thus, in order to afford our desired vinyl ether, a different approach was attempted in this 
MSc. Ruthenium-mediated catalysis has, in addition to RCM, also gained popularity for 
the isomerisation of terminal alkenes to internal alkenes. Examples of this type of 
isomerisation reactions coupled with RCM have recently been published by our group,57-
59 and the ruthenium isomerisation catalyst of choice, compound 119 (Figure 18), has 
been extensively studied60,61 and found to be particularly robust.  
 
[RuClH(CO)(PPh3)3]
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Figure 18 
 
Our diallyl ether 87 was then subjected to a two step/one pot procedure, by adding 0.5 
mol% of the isomerisation catalyst 119 to the ether 87 under solvent-free conditions, 
followed by heating the mixture to 90 °C for 3 hours. The expected isomerised 
intermediate was not isolated as in situ isomerisation followed by the addition of Grubbs 
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II catalyst 113 has been shown to result in higher yields of the ring closed product in 
some of our other projects. The Grubbs II catalyst 113, in dry, degassed toluene was then 
added, and the resulting solution was cooled down to 70 °C and left stirring for 24 hours 
(Scheme 30).  
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Scheme 30 Reagents and conditions: (i) Ru isom. cat., 119, 90 °C, 3 h; (ii) toluene, Grubbs II 
cat. 113, 70 °C, 24 h, overall yield 85%. 
 
The 1H NMR spectrum of the isochromene 86 formed was greatly simplified compared to 
that of the allyl ether 87. Most notable was the disappearance of the various multiplets for 
the O- and C-allyl substituents. The singlet for the two benzylic protons was shifted 
downfield from δ 4.57 to δ 5.11. In addition, the proton 4-H gave rise to a signal at δ 
6.56, as expected for a vinyl proton. In the 13C NMR spectrum similarly we noted the 
disappearance of 4 signals depicting the loss of butene. The new signals for C-4 and C-3 
were now found at δ145.6 and δ 99.4 respectively, as expected for vinyl ether alkene 
protons. Additional proof for the formation of the ring closed product was found from 
high resolution mass spectroscopy which gave a molecular ion of m/z 192.0797. The 
isochromene 86 required a mass of 192.0786. 
 
2.1.2 The Synthesis of Isochroman-4-ol by Hydroboration-Oxidation 
 
Hydroboration reactions are versatile and commonly used reactions in synthetic organic 
chemistry for the reduction of almost any non-aromatic carbon-carbon multiple bond. In 
addition, oxidation of the borane-substrate intermediate to yield alcohols has been well 
documented.62,63 With the introduction of various chiral alkyl boranes, stereoselective 
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reduction of multiple bonds are also possible. Since the chiral hydroboration-oxidation 
reaction on this particular substrate has been previously attempted with no success,64 we 
decided to continue with the achiral route producing the racemic product 85 (Scheme 
31), which we wished to then subject to an alternative, novel method in order to separate 
the enantiomeric benzylic alcohols. 
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Scheme 31 Reagents and conditions: (i) Borane-methyl sulfide complex, THF, 0 °C → rt; 2 h; 
(ii) NaOH, H2O2, 24 h. 
 
The racemic benzylic alcohol 85 was produced as expected by treating a tetrahydrofuran 
solution of the isochromene 86 with the achiral borane-methyl sulfide complex followed 
by oxidation of the resulting mixture with aqueous sodium hydroxide and hydrogen 
peroxide. Spectroscopic analysis confirmed unequivocally that rac-85 was produced. The 
vinyl proton signal at δ 6.56 in the 1H NMR spectrum was no longer observed. The two 
benzylic methylene protons were now non-equivalent and appeared as two doublets at δ 
4.85 and δ 4.51 with geminal coupling constants of J=16.0 Hz. The splitting patterns for 
4-H and 3-H were now more complicated. The signal for 4-H shifted upfield to δ 4.79 
from δ 6.56. The signal for 3-H shifted from a doublet at δ 6.04 to two doublet of 
doublets at δ 4.08 and δ 3.78. In addition the new 4-hydroxyl signal was observed as a 
broad singlet at δ 2.88. The notable features in the 13C NMR spectrum were the shifts of 
the signals for C-4 (δ 145.6 to δ 60.3) and C-3 (δ 99.4 to δ 70.3). The IR spectrum 
showed a prominent broad band at 3447 cm-1 for the hydroxyl stretch. The mass spectrum 
showed a molecular ion at m/z 210.0904 consistent with the formula C11H13O4 (calculated 
210.0892) thus further confirming the formation of the racemic alcohol 85.  
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2.1.3 Enantiomeric Discrimination 
 
We have previously discussed the benefits of transition metal catalysts in our ring closing 
step, which has become a common tool used by synthetic organic chemists. Another 
increasingly popular synthetic tool, from another related field of science, which has 
become increasing useful is biocatalysis.65 We wished to use this methodology in order to 
separate the two enantiomeric benzylic alcohols of 85. 
 
2.1.3.1 Introduction into Biocatalysis 
 
Living cells are capable of carrying out a huge range of enzyme-catalysed chemical 
transformations, some of which have little or no precedence in synthetic organic 
chemistry.66 Enzymes are remarkable catalysts, which are capable, not only of accepting 
a wide range of substrates, but also of exhibiting high chemo-, regio- and 
enantioselectivity.67 It is due to these remarkable catalytic properties that there is an 
increasing interest in elucidating and exploiting these biological catalysts in organic 
synthesis. These giant macromolecules, possess a highly complex three dimensional 
structure arising from the spontaneous folding of a polypeptide chain, which is a linear 
sequence of amino acid building blocks joined together by amide linkages. It is this 
complex structure which affords high enantioselectivity in the reactions catalysed. The 
price and availability of enzymes has also significantly decreased over the past few years, 
also making them more economically attractive catalysts.  
 
The part of the enzyme’s complex tertiary structure, which is responsible for carrying out 
the chemical reaction, is known as the ‘active site’. It is usually a hydrophilic cleft or 
cavity which contains an array of amino acid side chains which bind to the substrate. 
Since this active site is chiral, it is naturally only able to bind to one enantiomer of the 
substrate. This high substrate selectivity is the hallmark of enzyme catalysis.66 The one 
application of enzymes that we have chosen to explore is their use in resolving racemic 
mixtures of alcohols into their optically active components by making use of the enzyme 
lipase. 
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2.1.3.2 Transesterification Reactions with the Enzyme Lipase 
 
Lipases are fat-soluble enzymes which play an important role in food digestion. They 
assist in the breakdown of fats, oils and lipid content in foods by hydrolyzing the ester 
functional groups. The lipase enzyme can also function in the opposite direction, that is, 
in the presence of an appropriate acyl donor; it can also acetylate the chiral alcohol. This 
transfer of functionality is referred to as transesterification. Since enzymes function 
stereospecifically and we intended to take advantage of this useful property to separate 
the two enantiomers of our racemic alcohol. The enzyme will acetylate one enantiomer of 
the alcohol to the corresponding acetate, while leaving the other enantiomer untouched. 
This will then facilitate the easy separation of the enantiomerically pure products. 
Deacetylation of the racemically prepared acetate as well will result in hydrolysis of one 
enantiomer and the other enantiomer unreacted. This thus provides us with an enzymatic 
method for the resolution of our enantiomers. The racemic acetate 89 was prepared for 
this purpose.  
 
2.1.3.3 The Synthesis of Isochromen-4-yl Acetate 89 
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Scheme 32 Reagents and conditions: (i) Ac2O, NEt3, DMAP, THF, 3 h, 70%. 
 
The conversion of the alcohol (±)-85 to the acetate (±)-89 was easily achieved in a yield 
of 70% by reacting a solution of the alcohol (±)-85 in THF with acetic anhydride and 
triethylamine and a catalytic amount of 4-dimethylaminopyridine (Scheme 32). There 
was a large shift in the Rf of the product on a silica gel TLC plate as compared to the 
starting material (0.34 to 0.80 in 50% EtOAc/hexane). Spectroscopic data confirmed the 
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complete conversion of the alcohol. The most prominent change in the 1H NMR spectrum 
was the absence of the broad hydroxy signal at δ 2.88 and new singlet, integrating for 
three protons at δ 2.09 confirming the presence of the methyl group of the acetate group 
attached. The signal for 4-H was shifted downfield (δ 4.79 to δ 5.93) due to further 
deshielding. All other signals were in line with expectations. The 13C NMR spectrum 
showed two new signals. The new ester carbonyl signal was found at δ 170.6 and the new 
COCH3 signal appeared at δ 21.2. All the other signals were as expected. The result of 
the high resolution mass spectrometry gave a molecular ion of m/z 252.0999 (Calculated 
for C13H16O5: m/z 252.0998). 
 
With the racemic acetate (±)-89 in hand we were now in a position for the enzymatic 
reaction. It was however necessary to determine the most suitable enzyme for the 
enantioselective conversion, as well as the optimal reaction conditions. This is discussed 
in the next section. 
 
2.1.3.4 Initial Lipase Screening 
 
There are an enormous amount of commercially available lipases, each one optimal for a 
specific substrate. They are available as different preparations, for example, in liquid 
buffers or adsorbed onto solid supports. Each enzyme functions optimally at certain 
temperature as well as with specific solvent systems and at optimal pH levels. In order to 
facilitate the testing of various commercially available enzymes and reaction conditions a 
range of substrates 120-127 with similar structures to our molecule of interest, 
isochromanol 85 were either purchased or produced in one step (reduction/acetylation) 
from suitable starting material. They are listed below in Figure 19. 
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Figure 19 
 
The initial screening involved the testing of a range of forty enzymes which are capable 
of facilitating the transformation. The five benzylic alcohol substrates (85 and 120-123) 
were subjected to an enzyme assisted acetylation reaction with the acyl donor, vinyl 
acetate, while the five acetate substrates (89 and 124-127) were subjected to an enzyme 
assisted hydrolysis reaction. This initial screening was done in isopropyl alcohol as the 
solvent and the buffer system employed was tris (hydroxymethyl)amino methane (Tris), 
which functioned at pH 8. With all the necessary reagents added, the reaction was 
allowed to proceed for two hours at 37 °C. due to the small scale of the reaction (mirolitre 
reactions), the confirmation of conversion was accessed by TLC analysis of the reaction 
mixture. From this general screening, five positive enzymes that performed well across 
the range of substrates were then selected. The list of the enzymes utilized in the 
screening procedure as well as the results obtained are given in Appendix A3.   
 
With the range of possible suitable enzymes narrowed down, it was now possible to 
assess various reaction conditions. This was done by altering the solvent used. Dioxane, 
tert-butylmethyl ether and toluene were tested for each substrate-enzyme combination. In 
addition to this, a corresponding reaction set was simultaneously run but with the addition 
of a detergent, sodium deoxycholate, in order to assess the effect on the enzyme 
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efficiency. From this run we were able to determine that our substrates functioned best 
with toluene as the solvent and in the absence of a detergent. The most favorable enzyme 
that performed well throughout the various reactions was identified as Novozyme 525, a 
commercial lipase from Candida antarctica. The de-acetylation reaction was chosen as 
the more favourable, less expensive alternative to the acetylation, which required a 
relatively expensive acyl donor, vinyl acetate. This screening process is summarized in 
Figure 20. 
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Figure 20 
 
With this enzyme in hand, a few more tests were run at varying temperatures and time 
intervals. Once again the chosen enzyme functioned well and proved to be resilient at 
both low and high temperatures (0 °C up to 40 °C).  
 
In the next section we will briefly discuss the proposed mechanism of action of the 
enzyme, before commencing on the enantioselective reaction of our substrate (±)-89. 
 
2.1.3.5 Mechanisms of the Lipase Enzyme 
 
Several members of the family of lipase enzymes contain the amino acid serine 128 
(Figure 21) in their active sites. It is a polar amino acid, with a hydroxyl side chain. Due 
to this side chain, the enzyme-substrate interaction probably involves hydrogen bonding. 
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Figure 21 
 
The following mechanistic considerations are based on the Candida antartica lipase B 
(CALB), for which numerous molecular modeling studies have been done.68 The active 
site in CALB contains the catalytic triad serine-histidine-aspartate, which are common to 
all serine hydrolyses. As we can see in Scheme 33, the serine amino acid of the active 
site of the enzyme makes use of hydrogen bonding in its interaction with the substrate, 
forming a tetrahedral intermediate. The reason for the high enantioselectivity of the 
enzyme towards chiral secondary alcohols is due to the fact that the active site also 
contains a small cavity called the stereospecificity pocket in which the secondary 
alcohols have to orientate one substituent during catalysis.69 
 
The transesterification then occurs by forming a covalent acyl enzyme and the release of 
the secondary alcohol. In the presence of water, the reaction will not be reversed and the 
alcohol will not be re-acetylated. Reaction of the enzyme with the alcohol and vinyl 
acetate, as the solvent, will form the same covalent acyl enzyme and transfer the acetate 
group from the acyl donor onto the alcohol. The enantioselectivity is determined by the 
steric requirements of the stereospecificity pocket. 
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Scheme 33 
 
Before commencing with the enzymatic resolution of the alcohol (±)-85 and acetate (±)-
89 substrates, we needed to confirm that the enantiomeric ratio of our racemic mixtures 
was 50:50. This was achieved using a reverse phase high performance liquid 
chromatography (HPLC) Chiralcel OD column, with hexane and isopropyl alcohol 
(80:20) as our eluent. As expected, we can see from the HPLC chromatograms of the two 
substrates, Figure 22 and Figure 23 for the isochroman-4-ol (±)-85, and the isochromen-
4-yl acetate (±)-89, respectively, that we have a 1:1 racemic mixture of the two 
enantiomers of each substrate. Both chromatograms show a common contaminant in both 
the samples with a retention time of around 4.47. 
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Figure 22 
 
 
 
 
Figure 23 
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2.1.3.6 Resolution of (+)-Isochroman-4-ol and (−)-Isochromen-4-yl Acetate 
 
Our initial approach involved the deacetylation of our racemic acetate (±)-89. This was 
regarded as a simpler option since no acyl donor was required and the commercial 
enzyme utilised, Novozyme 525, was available in a buffered solution of the lipase 
enzyme. Any water present would not affect the hydrolysis process. Since there was no 
readily available information of the liquid preparation of the enzyme, it was also 
necessary to prepare a buffer solution for the optimum activation and functioning of the 
enzyme. The buffer solution employed was that of tris (hydroxymethyl)amino methane 
(Tris HCl) buffer, which maintained the suspension at a pH of 7.5. The acetate was 
dissolved in a minimal amount of toluene and to this was added the buffer solution, 
followed by the enzyme suspension. The reaction mixture was stirred for 2 hours at room 
temperature. Completion of the reaction was confirmed by normal phase HPLC on a C18 
column, which showed a 50% conversion of the starting material to what we hoped 
would be one specific enantiomer of the alcohol. The organic phase was then extracted 
with EtOAc and dried. The products were analysed using reverse phase HPLC under the 
same conditions as above in order to determine the enantiomeric ratio. This is shown in 
Figure 24. 
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Figure 24 
 
On comparison of the reaction mixture chromatogram Figure 24 with that of the 
substrate chromatograms Figure 22 and 23, we can see that only one enantiomer of the 
acetate was hydrolysed to what we presumed to be the corresponding chiral benzylic 
alcohol, while the other enantiomer remained unreacted. The enantiomeric ratio of the 
alcohol was determined to be greater than 98% from the ratio of the area under the peaks.  
 
The products from the reaction mixture were separated using silica gel column 
chromatography, to give us the single enantiomers of the acetate (−)-89 (30%) and the 
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alcohol (+)-85 (33%). The 1H and 13C NMR spectra of the enriched enantiomers of 85 
and 89 matched that of the racemic counterparts identically. A 1% solution of each 
compound in chloroform was prepared in order to measure the optical rotation. The 
unreacted isochromen-4-yl acetate 89, gave an optical rotation of [α]D= −93.0 and the 
enantioselectively hydrolysed isochroman-4-ol 85, showed an optical rotation of [α]D= 
+28.0.  
 
The (+)-alcohol (+)-85 was then chemically acetylated using the same procedure as that 
subjected to the racemic alcohol. The product (+)-89 obtained in 81% yield was similarly 
purified and analysed to confirm the acetylation. This product was then also analysed for 
optical rotation and found to give an optical rotation of [α]D= +72.0.(c= 1 in CHCl3). 
While the direction of rotation of light was in line with expectations, the value was not. 
This may be due to several contributing factors of concentration, temperature etc which 
greatly affect the sensitivity of the polarimeter.  
 
Similarly the enriched (−)-acetate (−)-89 was subjected to a deacetylation, using 
potassium carbonate in methanol. The reaction was established to be complete by TLC. It 
was purified and analysed spectroscopically to confirm the conversion to (−)-85 in a yield 
of 82%. Analysis on the polarimeter of a 1% solution in CHCl3 gave a reading of [α]D= 
−41.0. Once again we have obtained a correct value for the direction of rotation of light, 
i.e. the opposite to the other optical isomer, however the value is different probably due 
to the same reasons outlined above. 
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CHAPTER 3: CONCLUSIONS AND FUTURE WORK: PART A 
 
3.1 Enantiomeric Resolution of Isochroman-4-ol 85 
 
The main aim of this project was the synthesis of the racemic benzylic alcohol 85, and its 
resolution into its stereoisomers with the use of biocatalysis. The racemic alcohol was 
synthesised over seven steps from the commercially available 1,5-dihydroxybenzoic acid 
106 (Scheme 34). The synthesis commenced with the diallylation of starting material 106 
to produce 107 in a 92% yield. This product was the subjected to thermal Claisen 
rearrangement to produce the hydroquinone 108 in 86%. Methylation to protect the 
phenols then resulted in 109 in 82%. This was followed by lithium aluminium hydride 
reduction of the ester to yield the benzyl alcohol 88 in 93% yield. The benzyl alcohol was 
then allylated to the allyl ether 87 in a 91% yield. 
 
OH
OH
OH
O OH
O
O
O OH
OH
O
O
OMe
OMe
O
O OMe
OMe
OH
OMe
OMe
O
8788109
108107106
(iii)
(v)(iv)
(ii)(i)
 
 
Scheme 34 Reagents and conditions: (i) K2CO3, allyl bromide, acetone, ∆, 24 h, 92%; (ii) 170 
°C, 18 h, 86%; (iii) K2CO3, Me2SO4, acetone reflux, 24 h, 82%; (iv) LiAlH4, THF, 40 °C, 2 h, 
93%; (v) allyl bromide, NaH, THF, reflux, 24 h, 91%. 
 
With the allyl ether in hand, the formation of the isochromene was accomplished over 
two steps with the ruthenium mediated isomerisation and ring closing metathesis (RCM) 
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reaction in a one pot/two step synthesis. The overall yield for this novel step was 85% 
(Scheme 35). Therefore the overall yield for this seven step procedure is an excellent 
47%. With the conditions for this transformation optimised, it can now be extended to the 
ring closing of other analogous substrates for example for the formation of C-1 
substituted isochromenes e.g. from 129 to 130 (Scheme 36). 
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Scheme 35 Reagents and conditions: (i) Ru isom. cat., 118, 90 °C, 3 h; (ii) toluene, Grubbs II 
cat. 112, 70 °C, 24 h, overall yield 85%. 
 
OMe
OMe
O
130
OMe
OMe
O
129
(i), (ii)
 
 
Scheme 36 
 
The isochromene 86 was then converted to our desired isochromanol 85 using the 
hydroboration reaction followed by oxidation. The achiral borane reagent used, a borane-
methyl sulfide complex, gave us a 1:1 racemic mixture of the alcohol 85 in a 84% yield. 
This alcohol was then converted to the acetate 89 under standard procedures to obtain 89 
in a yield of 70% (Scheme 37). 
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Scheme 37 Reagents and conditions: (i) Borane-methyl sulfide, THF, 0 °C→rt, 2 h; (ii) NaOH, 
H2O2, 24 h, 84%; (iii) Ac2O, NEt3, DMAP, THF, 3 h, 70%. 
 
The lipase enzyme, Novozyme 525 was then used to hydrolyse the (+)-enantiomer of our 
acetate (±)-89 producing the corresponding (+)-alcohol (+)-85, while leaving the (−)-
acetate (−)-89 unreacted (Scheme 38). 
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Scheme 38 Reagents and conditions: (i) toluene, buffer soln (pH 7.5), lipase enzyme, 2 h, 33% 
(+)-85, 30% unreacted (−)-89. 
 
We were then able to chemical convert our enantiomerically pure (+)-isochromanol (+)-
85 to the corresponding (+)-acetate (+)-89 in a yield of 81%; as well as the (−)-acetate 
(−)-89 to the (−)-alcohol (−)-85 in a yield of 82% while retaining the stereochemistry. 
 
The next crucial step will be the derivatisation of the optically active alcohols (+)- and 
(−)-85 in order to obtain crystal structures of the molecules and thus assign their absolute 
configuration according to the Cahn-Ingold-Prelog rules. Thereafter we will try to 
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introduce substituents at the C-1 and C-3 positions of the isochromanol nucleus (Figure 
25) using arene-tricarbonyl complexes as outlined below. 
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Figure 25 
 
3.2 The Chemistry of Arene-Tricarbonylchromium Complexes 
 
It has been found that that the Cr(CO)3 moiety, when attached to an arene ligand, is able 
to facilitate transformations that the free arene ligand is incapable of.70 Some of these 
novel properties are summarised in Figure 26.  
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Figure 26 
 
The arene-Cr(CO)3 complexed carbanions are stabilized at the benzylic position,71 and 
regio- and stereo-selective products can be obtained via the benzylic carbanions 
depending on the orientation of the Cr(CO)3 to the arene.72 
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Scheme 39 Reagents and conditions: (i) [Cr(CO)6], n-Bu2O/heptane/THF (1:1:0.1), Argon, 120 
°C, 36 h.73 
 
Moreover on complexing to the arene ligand in our case the isochromanol 85, the 
Cr(CO)3 should complex on the same side as the enantiomerically pure benzylic alcohol 
function thus forming the single diastereomer 131 (Scheme 39). Due to the steric 
hindrance of the metal complex one face of the molecule is shielded and therefore 
substituents can now be added to the C-1 and C-3 positions in a stereoselective manner.  
 
For the addition of substituents to both these positions we envisage oxidation of the 
secondary alcohol 131 to the ketone 132. The chiral information is now stored as a chiral 
planar complex. Then by using a suitable base to abstract the acidic protons from both the 
desired C-1 and C-3 positions, we should be able to access these positions from the 
opposite face of the chromium tricarbonyl tripod to produce 133 followed by 134. 
Furthermore, reduction of the ketone should also proceed in a similar stereoselective 
manner to finally give us, after decomplexation of the Cr(CO)3 moiety, the compound 
135, with stereo defined substituents in the C-1, C-3 and C-4 positions. This strategy is 
depicted in Scheme 40. 
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Scheme 40 
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CHAPTER 4: RESULTS AND DISCUSSION: PART B 
 
At this point we decided to start with the other part of the MSc. i.e. the construction of 
the biaryl naphthalene portion of the cardinalin 3 23 nucleus (Figure 27).  
 
O
O
O23
O
O
O
OMe
OH
MeO
OH
 
 
Figure 27 
 
4.1 Synthesis of the Biaryl Axis 
 
Biaryls are available through the coupling of the aryl halide with an excess of copper at 
elevated temperatures. This classic transition metal mediated dimerisation is well known 
as the Ullmann reaction.74 
 
4.1.1 The Ullmann Reaction 
 
There is a universal acceptance that the formation of biaryl axis in the Ullmann reaction 
involves the interaction of an aryl copper species with an aryl halide, although the mode 
of coupling is controversial.75 The mechanism may involve the formation of σ or π 
complexes with the halogen atom, polarizing the bond. The metal may also undergo 
oxidation and subsequent reduction to afford the coupled product through either one 
electron transfers or electron pair processes.76  
 
While the actual mechanism of the copper mediated homo-coupling of aryl halides has 
not been entirely elucidated, it has been proposed that the Ullmann type reactions 
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proceeds through a cycle, and in one proposed mechanism, a copper(I) compound 137 
formed from the lithiated species 136, forms the active species which is then postulated 
to undergo oxidative addition with the second equivalent of the aryl halide 138 to form a 
Cu(III) species 139. This is followed by reductive elimination and the formation of the 
aryl-aryl carbon bond in compound 103.77 This cycle is depicted in Scheme 41 with our 
molecule of interest 138, and the aryl cuprate 137, as our Cu(I) species.  
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Scheme 41 
 
There are various known modifications of the Ullmann reaction. The approach used in 
this project was the coupling of a preformed aryl copper intermediate with an aryl 
halide.78 Our aryl halide of choice was iodo-1,3-dimethoxybenzene 138. The ease of 
halogen displacement from an aromatic ring is generally I>Br>Cl>F.79 This is opposite to 
the trend observed in uncatalysed aromatic nucleophilic substitution reactions.80  
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Our synthesis of the one partner of the Ullmann reaction, 2-iodo-1,3-dimethoxybenzene, 
138, began with the lithiation of 1,3-dimethoxybenzene 102 at 0 °C, giving a milky white 
solution. This was followed by the addition of a solution of iodine in tetrahydrofuran. The 
completion of the reaction was clearly visible by the appearance of the darker halogen 
colour, once all the aryl lithium intermediate 136 had reacted. The product was extracted 
from the reaction mixture and recrystallised from a dichloromethane-ethanol mixture to 
yield 93% of the desired aryl halide 138 (Scheme 42).  
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Scheme 42 Reagents and conditions: (i) n-BuLi, THF, 0 °C, 1 h; (ii) I2, THF, rt, 1h, 93%. 
 
Spectroscopic data unequivocally confirmed the identity of the molecule 138. The 1H 
NMR spectrum was highly simplified due to the C2 axis of symmetry of the molecule. 
The aromatic region contained two signals, a triplet integrating for one proton, 5-H, and a 
doublet integrating for the two equivalent protons, 4-H and 6-H. Both signals had 
coupling constants of J=8.3 Hz, indicative of ortho coupling.  The absence of a singlet in 
the aromatic region for 2-H confirmed that substitution of the proton with our halide had 
indeed taken place. The other signal in the spectrum was a singlet at δ 3.89, integrating 
for six protons, assigned to the methoxy groups. There were only five signals in the 13C 
NMR spectrum due to the symmetry of the molecule. All the signals were in line with 
expectations. The aromatic CO signals were further downfield at δ 158.4, followed by C-
5 and ArC-I and finally C-4 and C-6. The signal for the methoxy carbons were found at δ 
56.1. Strongest confirmation for the aromatic iodide compound 138 was received from 
the high resolution mass spectrum. The molecular ion was found at m/z 263.9654, and the 
molecule C8H9IO2 required M+ 263.9647. 
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The formation of the aryl copper intermediate 137 similarly began with the lithiation of 
1,3-dimethoxybenzene 102 at 0 °C. This was followed by the addition of copper(I) iodide 
to facilitate the transmetallation at room temperature. This intermediate 137 was not 
isolated and characterized. The iodated aryl compound 138, dissolved in pyridine, was 
then added and the resultant mixture was heated at reflux for 72 h. It has previously been 
found that the addition of potential ligands for the copper(I) atom, like pyridine, was 
found to enhance the rate of halogen exchange.81 This may play a role in the ease of 
displacement of the halogen from the aryl halide by the copper compound in the 
oxidative addition step. After an acid workup, the extracted crude material was 
recrystallised from a dichloromethane-ethanol mixture to yield the desired 2,2′,6,6′-
tetramethoxy-1,1′-biphenyl 103, (Scheme 43) in 93% yield. The Ullmann reaction has 
been found to proceed faster with aryl halides that are substituted in the ortho position 
with groups that contain lone pairs of electrons, regardless of whether they are electron 
donating or electron withdrawing.82 
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Scheme 43 Reagents and conditions: (i) n-BuLi, CuI, 0 °C, 3 h; (ii) 138, pyridine, reflux, 72 h, 
93%. 
 
The 1H NMR spectrum as well as the 13C NMR spectrum, while giving all the signals as 
expected, was not very useful in confirming the synthesis of the biaryl axis. This was due 
to the fact that once again we have formed a symmetrical molecule, with two C2 axis of 
symmetry, which resulted in minimal signals in both spectra. Moreover the aromatic ring 
of 103 has the same substitution pattern as the iodated precursor 138 therefore giving 
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similar carbon and hydrogen signals, with slight shifts in the δ values. Confirmation of 
the formation of the dimer therefore came from the high resolution mass spectrum, which 
showed a molecular ion of m/z 274.1198. (C16H18O4 requires M+ 274.1205).  
 
Another popular alternative for the homocoupling of aryls is through the use of palladium 
catalysis in the Suzuki coupling of the arylboronic acids with aryl halides.83 Palladium 
salts are however more expensive than copper salts and require the use of various 
sophisticated ligands such as phosphines, and have a higher toxicity. Although there have 
been numerous advances in this protocol, some substrates still give a poorer yield when 
compared to the Ullmann dimerisation.84 Although in some cases steric hindrance does 
inhibit Ullmann coupling, the effect is more pronounced in Suzuki couplings.85 The 
Ullmann reaction has therefore remained the reaction of choice for large scale 
syntheses.86 This alternative was also investigated and is discussed in the next section. 
 
4.1.2 The Suzuki Coupling Reaction 
 
In order to explore both alternatives of the biaryl coupling reactions, the boronic acid of 
1,3-dimethoxybenzene was prepared by once again lithiating the substrate, 1,3-
dimethoxybenzene 102, at the 2 position and then reacting this intermediate with 
trimethyl borate. The new borate formed was then acidified in order to form the desired 
boronic acid, 139. (Scheme 44)  
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Scheme 44 Reagents and conditions: (i) n-BuLi, THF, 0 °C, 1 h; (ii) B(OMe)3, 0 °C, 18 h; (iii) 
HCl. 
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Once again the number of protons in the 1H NMR spectrum  are halved due to the C2 axis 
of symmetry of 139. The 1H NMR spectrum of the boronic acid closely resembled that of 
the previous halide as well as the biphenyl, but with an additional singlet at δ 7.22 
integrating for the two new protons of the boronic acid group. The 13C NMR spectrum 
also closely resembled the previously synthesized iodo complex 138, with one key 
difference; the C-2 carbon was now attached to an electropositive boron atom and was no 
longer deshielded to a large extent. This signal in the 13C NMR spectrum shifted upfield 
to δ 55.8, as opposed to δ 112.6 for the C-2 attached to iodine in 138. The result of the 
high resolution mass spectrometry gave a molecular ion of m/z 182.0761 (Calculated for 
C8H11BO4: m/z 182.0750). For the Suzuki coupling reaction, the aryl halide used was 
once again the iodide 138, simply because it was readily available to us. 
 
The Suzuki coupling reaction proceeds through a catalytic cycle in which a carbon-
carbon bond is formed between the carbon of 139 bearing the boronic acid and the carbon 
of 138 bearing the halide. The reaction makes use of a palladium catalyst, in this case, 
tetrakis(triphenylphosphine)palladium(0) [Pd(PPh3)4] 140 to effect the transformation. In 
this mechanism, the boronic acid 139 needs to be activated with a base to form 143. This 
activation enhances the polarisation of the organic ligand, to facilitate the 
transmetallation. The catalytic cycle is depicted in Scheme 45.87 The reaction begins by 
the oxidation of the Pd(0) catalyst 140 with the aryl halide 138 to give a Pd(II) 
intermediate 141. This Pd(II) complex then undergoes a transmetallation with the base-
activated boronic acid, expelling the aryl group onto the Pd to form 144. The base 
activation of the boronic acid adds a nucleophile into the low lying orbitals of the boron, 
hence forming a borate 143. Reductive elimination follows to give the coupled product 
103 with a new carbon-carbon bond as the biaryl axis. 
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Scheme 45 
 
In the formation of our biaryl axis, using Pd(PPh3)4 as our catalyst and aqueous sodium 
carbonate as our base, we were able to obtain our dimer 103 in a yield of 54% from the 
coupling of 138 and 139. This was significantly lower than that of the previous procedure 
and therefore not a viable alternative for the start of our linear synthesis. Falck and co-
workers84 were able to improve this yield to 75% through the homocoupling of the 
boronic acid using Ag2O and catalytic CrCl2 in THF under mild conditions (65 °C for 10-
12 h). This procedure too would thus fail to compete with the classic Ullmann approach. 
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4.2 The Synthesis of the Dicarbaldehyde 104 
 
The next step in our synthesis was the formylation of our biphenyl precursor 103. The 
classic formylation reaction published by Vilsmeier and Haack in 192788 makes use of 
the salt 147, formed from formamides and acid chlorides to formylate aromatic 
compounds, the most common being dimethylformamide (DMF) 145 and phosphoryl 
chloride (POCl3) 146. The salt 147 reacts with the substrate in an electrophilic 
substitution reaction yielding an iminium salt 148, which is then hydrolysed to the 
aldehyde 104 (Scheme 46).  
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Scheme 46 
 
This classic reaction however failed to yield our desired dicarbaldehyde 104, even after 
refluxing for more than 9 days. The phosphoryl chloride 146 was substituted by 
trifluoromethanesulphonic anhydride, in the hope of forming a more reactive iminium 
salt for our less activated aromatic compound,89 but still with no success 
 
We then attempted a variant of the Vilsmeier-Haack reaction, the Rieche formylation, 
first described by Gross et. al90 which involves the titanium-mediated formylation of 
sterically hindered aromatics. The reaction makes use of dichloromethyl methyl ether in 
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the presence of titanium(IV) chloride. The reaction could take place through the 
following proposed mechanism shown in Scheme 47.91 The substitution takes place at 
the ortho position to form our desired 104. The regioselectivity of the reaction can be 
explained in terms of the coordination of the titanium atoms with the oxygen atoms of the 
methoxy groups forming the intermediate 149 which results in 150. This coordination not 
only favours the desired regioselectivity, but also increases the electrophilicity of the 
dichloromethyl methyl ether and thus the rate of the reaction.91 
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Scheme 47 
 
For our desired diformylation, four equivalents of TiCl4 were added to a solution of our 
tetramethoxy biphenyl 103 in dry dichloromethane. The clear solution immediately 
changed to a bright orange colour. The reaction mixture was then cooled to −78 °C and 
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2.8 equivalents of the dichloromethyl methyl ether was added. The solution then 
darkened to brown. After a reaction time of 1 h, the reaction mixture was poured over ice 
and acidified with aqueous HCl to produce a bright pink organic phase. The reaction 
mixture was extracted with organic solvent and the residue was purified by silica column 
chromatography to produce our desired dicarbaldehyde 104, in an excellent yield of 95% 
(Figure 28). 
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Figure 28 
 
Spectroscopic analysis of the compound in hand confirmed that we had indeed 
accomplished the formylation reaction at both the desired ortho positions. The 1H NMR 
spectrum had a new signal at δ 10.17 for the two equivalent aldehyde groups. The 
aromatic region now changed from a doublet integrating for four protons and a triplet 
integrating for two protons to two doublets integrating for two protons each. Both the 
signals exhibited coupling constants of J=8.8 Hz, indicative of an ortho relationship. The 
signals for the methoxy groups were found at δ 3.76 and δ 3.52. The number of signals 
were again an indication of the two C2 symmetries of the molecule. The new signals for 
the aldehyde groups were found in the 13C NMR spectrum at δ 188.8. The signals for C-2 
and C-6 were now found at δ 163.5 and δ 162.7. Similarly the signals for C-3 and C-5 
were also separated, appearing at δ 123.1 and δ 107.1. The signals for the equivalent 
methoxy substituents were found at δ 63.0 and δ 56.1. The formula C18H18O6 required a 
molecular ion of m/z 330.1103 and the parent ion on our high resolution mass spectrum 
was found at m/z 330.1093. 
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The 2,2’,6,6’-tetramethoxy[1,1′-biphenyl]-3,3′-dicarbaldehyde 104 was recrystallised 
from a dichloromethane-ethanol mixture and the white crystals afforded (mp. = 151-155 
°C) were subjected to single crystal X-ray diffraction analysis. The information obtained 
is summarised in Appendix A4. From our structure we can clearly see the two C2 axis of 
symmetry of our molecule. Due to the steric effect of the tetrasubstitution of the methoxy 
groups, the two benzene rings are orientated perpendicular  to each other. Also the 
methyls of the methoxy groups para to the formyl groups are planar with respect to the 
ring, whereas with the substituents ortho to the aldehydes, the methyl group of the 
methoxy, lies out of this plane as shown in Figure 29. 
 
 
 
Figure 29 
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With our diformylated biphenyl 104 in hand we are now able to continue with our 
planned bi-directional synthesis as per the methodology developed for the synthesis of 
the naturally occurring monomer, ventiloquinone L.48  
 
4.3 The Synthesis of the Bis-acetoxynaphthalenecarboxylic Acid Ethyl Ester 105 
 
The synthesis of the dimer of the acetoxynaphthalenecarboxylic acid ethyl ester 105, was 
achieved through the Stobbe condensation followed by a Friedel-Crafts acylative 
cyclisation of 104 (Scheme 48). 
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Scheme 48 Reagents and conditions: (i) Diethyl succinate, tBuOH, KOtBu; (ii) NaOAc, Ac2O. 
 
The Stobbe condensation is the reaction of aldehydes or ketones with an ester of succinic 
acid to form alkylidenesuccinic acids (e.g. 151).92 For our desired product we made use 
of diethyl succinate and the base employed was potassium t-butoxide to form 152. The 
success of the reaction and the specificity of the succinic ester is associated with the 
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juxtaposition of a carbethoxyl group for the ring formation in 154 as shown in Scheme 
49 below, which is then cleaved by an alkoxide to form the unsaturated half ester 151. 
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Scheme 49 
 
The alkylidene acid 151, which was isolated and used without further purification, can 
now undergo a cyclodehydration. This is possible due to the appropriate stereochemical 
configuration of the aryl group being cis to the –CH2COOH group.92 Our cyclisation was 
achieved using sodium acetate and acetic anhydride to give us the bis-acetate 105 
(Figure 30). This is effectively a Friedel-Crafts acylative cyclisation reaction. The bright 
yellow product 105, was produced in an overall yield of 60% over the two steps.  
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Figure 30 
 
The confirmation of the success of the cyclisation was unequivocally displayed in the 1H 
NMR spectrum of 105. There was no longer a signal for the aldehyde proton present, and 
the aromatic region was now occupied by 3 singlets for protons 1-H, 3-H and 5-H. The 
presence of the ethyl group was confirmed by the expected typical splitting pattern of a 
quartet (at δ 4.43) and triplet (at δ 1.42), integrating for 2 and 3 protons respectively. 
There was a substantial increase in the number of signals in the 13C NMR spectrum on 
the conversion of the dialdehyde 104 into diarylnaphthalene 105. The new carbonyl 
signals for the acetate and the ester groups were found at δ 169.4 and δ 166.2 
respectively. In addition there were now three aromatic hydrogen bearing carbon signals 
at δ 123.9, δ 118.9 and δ 94.9. The aromatic region of the spectrum now also contained 
five signals for carbons bearing no hydrogens. The signal for the methyl group of the 
acetate was found at δ 21.0 and the signals for the carbons of the ethyl group were at δ 
61.1 and δ 14.4. The high resolution mass spectrum of the molecule C34H34O12 was found 
at m/z 634.2038. The required mass was calculated to be m/z 634.2051. 
 
As the research of both Part A and Part B was relatively successful, this work will be 
continued in a PhD study. 
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK: PART B 
 
5.1 Progress towards the Synthesis of Cardinalin 3 23 
 
Based on the synthesis of ventiloquinone L 10 (Chapter 1, Schemes 18 and 19), we 
were able to disconnect the molecule 23 back to the tetra-substituted biphenyl 103 which 
already has the C8-C8′ biaryl axis of cardinalin 3 23 in place (Scheme 50).  
 
O
O
O23
O
O
O
OMe
OH
MeO
OH
103
OMe
OMe
MeO
OMe
 
 
Scheme 50 
 
5.1.1 Biaryl Bond Formation 
 
The formation of the C8-C8′ biaryl bond was accomplished via two alternative routes. In 
the Suzuki coupling reaction, the iodo-complex 138 was coupled to the boronic acid 139 
(Scheme 51), however the yield of this reaction was a disappointing 54%.  
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Scheme 51 Reagents and conditions: (i) Pd(PPh3)4, DME, aq. Na2CO3, 18 h, 54%. 
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The coupling was also attempted using the conditions of the classic Ullmann reaction. 
This route proved far more rewarding as the biphenyl 103 was obtained in a yield of 
93%. Here the iodo-aryl 138 was coupled to the cuprate halide 137, which was 
synthesised in situ from 1,3-dimethoxybenzene (Scheme 52). 
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Scheme 52 Reagents and conditions: (i) n-BuLi, CuI, 0 °C, 3 h; (ii) 138, pyridine, reflux, 72 h, 
93%. 
 
5.1.2 Formation of the Bis-naphthalene 105 
 
Diformylation of 103 was achieved with the Rieche formylation procedure in a yield of 
95%, and this product 104 was subjected to Stobbe condensation followed by an 
intramolecular Friedel-Crafts acylation to give us the bis-naphthalene 105 (Scheme 53) 
in an acceptable yield of 60% over the two steps. 
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Scheme 53 Reagents and conditions: (i) TiCl4, Cl2CHOCH3, CH2Cl2, −78 °C→ 0 °C, 2 h, 95%; 
(ii) (a) diethyl succinate, tBuOH, KOtBu; (b) NaOAc, Ac2O, 60%. 
 
With the molecule 105 in hand we can now, for future work, continue towards the 
synthesis of cardinalin 3 23, using the methodology developed for the synthesis of 
ventiloquinone L 10.48 In addition on formation of the 1,3-dimethyl pyran ring we will be 
able to now use the methodogy developed on utilising enzymes, and following this, then 
use the arene-tricarbonyl complex chemistry to our advantage to hopefully introduce 
substituents at the C-1 and C-3 positions in a stereoselective manner onto the pyran 
nucleus (Scheme 54). 
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Scheme 54 (i) Acetate hydrolysis, O-allylation, Claisen rearrangement; (ii) benzylation, 
reduction of ester; (iii) O-allylation, isomerisation and RCM; (iv) hydroboration, 
enzymatic enantiomeric resolution, chromium complexation, stereo-selective 
methylation, de-oxygenation of benzylic alcohol; (v) de-benzylation, salcomine 
oxidation, selective demethylation. 
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CHAPTER 6: EXPERIMENTAL PROCEDURES 
 
6.1 General Experimental Procedures 
 
6.1.1 Purification of Solvents and Reagents 
 
All solvents used for reactions and preparative chromatography were distilled prior to 
use. Where necessary, they were also dried by standard methods as recommended by 
Perrin et al.93 Tetrahydrofuran, was distilled from the sodium benzophenone ketyl 
radical; dichloromethane, and triethylamine from calcium hydride and toluene from 
sodium. Chloroform was dried from passage through basic alumina (ICN Adsorbentien, 
ICN Alumina Super I). Where necessary, solvents were stored over activated molecular 
sieves (4 Å) under a nitrogen atmosphere. Potassium tert-butoxide was sublimed prior to 
use. Unless otherwise noted, other reagents were obtained from commercial sources and 
used without further purification. 
 
6.1.2 Chromatographic Separations 
 
The Rf values quoted are for analytical thin layer chromatography (TLC) on aluminium-
backed Macherey-Nagel Alugram Sil G/UV254 plates pre-coated 0.25 mm silica gel 60, 
detection by UV-absorption. Preparative column chromatography was carried out on both 
wet- and dry-packed columns using Macherey-Nagel Kieselgel 60 silica gel 60 (particle 
size 0.063-0.200 mm) as the adsorbent. Mixtures of EtOAc and hexane were used as the 
mobile phase. 
 
High performance liquid chromatography (HPLC) was carried out on a Hewlett Packard 
Series 1050 system, with a Chiralcel OD reverse phase column. 
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6.1.3 Spectroscopic and Physical Data 
 
All melting points were obtained on a Reichert hot-stage microscope, and are 
uncorrected. 
 
1H NMR (nuclear magnetic resonance) spectra were recorded on a Bruker AVANCE 300 
(300.13 MHz) or a Bruker 400 (400.13 MHz) spectrometer. Spectra were recorded in 
deuterated chloroform (CDCl3) and chemical shifts are reported in parts per million 
downfield from tetramethylsilane, the internal standard; coupling constants are given in 
Hertz. Splitting patterns are designated as “s”, “d”, “t”, “q” and “m”; these symbols 
indicate “singlet”, “doublet”, “triplet”, “quartet” and “multiplet” respectively. NMR data 
are reported as follows: chemical shift (integration of signal, description of signal, 
coupling constant(s) where applicable, assignment). 
 
13C NMR (1H decoupled) spectra were recorded on a Bruker AVANCE 300 (75.47 MHz) 
or Bruker DRX 400 (100.63 MHz) spectrometer. Spectra were recorded in deuterated 
chloroform (CDCl3) and chemical shifts are reported in parts per million relative to the 
central signal of deuterated chloroform, taken as δ 77.00. 
 
IR (infrared) spectra were recorded on a Bruker IFS-25 Fourier Transform spectrometer 
or on a Bruker Vector-22 Fourier Transform spectrometer. Liquid samples were recorded 
as thin films between sodium chloride plates, while solid samples were recorded as 
solutions in chloroform in sodium chloride cells. The signals were reported on the 
wavenumber scale (ν/cm-1). Signals were designated as “s”, “m”, “w” and  “br”; these 
symbols indicate “strong”, “medium”, “weak” and “broad” respectively. IR spectra data 
were reported as follows: wavenumber (intensity, assignment). 
 
High resolution mass spectra were recorded on a Kratos MS 9/50, VG 70E MS or a VG 
70 SEQ mass spectrometer.  
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Optical rotations were measured on a Jasco DIP 3-70 instrument at 22 °C at the sodium D 
line, and [α]D values are given in deg.cm2.g-1. 
 
6.1.4 Crystal Structure Solution and Refinement 
 
Intensity data were collected at 20 °C on a Bruker SMART 1K CCD area detector 
diffractometer with graphite monochromated Mo Kα radiation (50 kV, 30 mA). The 
collection method involved ω-scans of width 0.3 °. Data reduction was carried out using 
the program SAINT+ and absorption corrections were made using the program 
SADABS.94 The crystal structure was solved by direct methods using SHELXTL.95 Non 
hydrogen atoms were first refined isotropically followed by an anisotropic refinement by 
full matrix least squares calculations based on F2 using SHELXTL. Hydrogen atoms were 
positioned geometrically and allowed to ride on their respective parent atoms. Diagrams 
and publication material were generated using SHELXTL and PLATON.96 
 
6.1.5 Other General Procedures 
 
The term “in vacuo” refers to the removal of solvent by rotary evaporation, followed by 
removal of the residual solvent at oil pump pressure (ca.0.1-1 Torr) at ambient 
temperature until constant mass was achieved. 
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6.2 Experimental Procedures Related to Part A 
 
6.2.1 Synthesis of Allyl 5-(allyloxy)-2-hydroxybenzoate 107 
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Potassium carbonate (11.94 g, 85.8 mmol, 2.2 equiv.) was added to a clear yellow 
solution of 2,5-dihydroxybenzoic acid (6.01 g, 39.0 mmol) in acetone (600 cm3), in a 2 
litre quickfit conical flask fitted with a condenser. The resulting mixture was heated to 30 
°C, while stirring under nitrogen. Allyl bromide (7.43 cm3, 10.38 g, 85.8 mmol, 2.2 
equiv.) was then slowly added to the solution by syringe. The resulting mixture was 
heated at reflux for 24 h, during which time it became a thick white paste. The reaction 
mixture was cooled, filtered through celite and the acetone then removed in vacuo. The 
residue was purified by silica gel column chromatography (20% EtOAc/hexane) to yield 
the diallylated product, as white needle-like crystals (8.42 g, 92%). Rf = 0.72 (20% 
EtOAc/hexane); mp. 43-45 °C, (lit97 43.5-44.5 °C); IR (CHCl3): νmax(cm-1) = 3440 (s, br, 
OH), 1649 (s, C=O), 1614 (s, C=C); 1H NMR (300 MHz, CDCl3): δH = 10.35 (1H, s, 
OH), 7.36 (1H, d, J=3.1, 6-H), 7.11 (1H, dd, J=9.1, J=3.1, 4-H), 6.92 (1H, d, J=9.1, 3-
H), 6.11-5.97 (2H, ddt, J=12.5, J=5.5, J=1.6, 2′ and 2″-H overlapped), 5.46-5.43 (2H, m, 
3′-H), 5.35-5.27 (2H, m, 3′′-H), 4.85 (2H, d, J=5.7, 1′-H), 4.50 (2H, d, J=5.3, 1′′-H); 13C 
NMR (75 MHz, CDCl3) δC = 169.5 (C=O), 156.3 (C-2), 151.0 (C-5), 133.2 (C-2′′), 131.5 
(C-2′), 124.6 (C-6), 118.9 (C-4), 118.5 (C-3), 117.7 (C-3′′), 113.5 (C-3′), 111.9 (C-1), 
69.6 (C-1′′), 65.8 (C-1′).  
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6.2.2 Synthesis of Allyl 2-allyl-3,6-dihydroxybenzoate 108 
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In a 50 cm3 RB flask equipped with a reflux condenser, neat allyl 5-(allyloxy)-2-
hydroxybenzoate (11.81 g, 50.4 mmol) was heated at 170 °C for 18 h, under a nitrogen 
atmosphere. The white powder melted to first form a yellow oil and then a deep orange 
liquid that became a black viscous oil. This was allowed to cool before purifying by silica 
gel column chromatography (5 →10 →20% EtOAc/hexane) to afford allyl 2-allyl-3,6-
dihydroxybenzoate as an viscous orange oil (10.14 g, 86%). Rf = 0.45 (20% 
EtOAc/hexane); IR (film): νmax(cm-1) = 3424 (s, br, OH), 1664 and 1610 (s, C=C); 1H 
NMR (300 MHz, CDCl3): δH = 10.34 (1H, s, 2-OH), 6.99 (1H, d, J=8.9, 4-H), 6.82 (1H, 
d, J=8.9, 3-H), 6.09-5.93 (2H, m, 2′ and 2′′-H overlapped), 5.45-5.32 (2H, m, 3′-H), 
5.11-5.02 (2H, m, 3′′-H), 4.86 (2H, m, 1′-H), 3.74 (2H, d, J=5.8, 1′′-H); 13C NMR (75 
MHz, CDCl3) δC = 170.5 (C=O), 156.1 (C-2), 147.3 (C-5), 136.3 (C-2′), 131.2 (C-2′′), 
126.4 (C-6), 123.4 (C-4), 119.7 (C-3), 116.6 (C-3′), 115.5 (C-3′′), 112.9 (C-1), 66.5 (C-
1′), 32.4 (C-1′′). 
 
6.2.3 Synthesis of Allyl 2-allyl-3,6-dimethoxybenzoate 109 
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In a 100 cm3 RB flask fitted with a condenser, potassium carbonate (8.50 g, 61.0 mmol, 
2.5 equiv.) was added to a clear yellow solution of allyl 2-allyl-3,6-dihydroxybenzoate 
(5.70 g, 24.4 mmol) in acetone (100 cm3), The solution was stirred at rt until it turned 
purple brown. Dimethyl sulfate (5.80 cm3, 7.70 g, 61.0 mmol, 2.5 equiv.) was then added 
by syringe and the resulting mixture was refluxed for 24 h. The crude reaction mixture, 
which was light brown in colour, was filtered through celite and the acetone was removed 
in vacuo. Once the residue cooled, diethyl ether (300 cm3) was added. The ether layer 
was washed with a 10% aqueous ammonia solution (300 cm3) until frothing stopped. The 
aqueous layer was thoroughly extracted with diethyl ether and dichloromethane. The 
organic extracts were combined and dried with anhydrous MgSO4 before filtering 
through celite. The solvent was removed in vacuo. After purification by silica gel column 
chromatography (20% EtOAc/hexane) allyl 2-allyl-3,6-dimethoxybenzoate was obtained 
as a clear yellow oil (5.26 g, 82%). Rf  = 0.47 (20% EtOAc/hexane); IR (film): νmax(cm-1) 
= 1731 (s, C=O), 1638 and 1598 (m, C=C); 1H NMR (300 MHz, CDCl3): δH = 6.84 (1H, 
d J=9.0, 4-H), 6.75 (1H, d, J=9.0, 5-H) 6.07-5.83 (2H, m, 2′ and 2′′ overlapped), 5.45-
5.26 (2H, m, 3′-H), 5.02-4.95 (2H, m, 3′′-H), 4.82 (2H, d, J=5.8, 1′-H), 3.78 (3H, s, 
OCH3), 3.77 (3H, s, OCH3), 3.35 (2H, d, J=6.3, 1′′-H); 13C NMR (75 MHz, CDCl3) δC = 
167.4 (C=O),151.6 (C-6), 150.2 (C-3), 135.9 (C-2′′), 131.9 (C-2′), 127.1 (C-1), 125.1 (C-
2), 118.6 (C-4), 115.3 (C-5), 112.4 (C-3′), 109.8 (C-3′′), 65.8 (C-1′) 56.4 (6-OCH3),  56.2 
(3-OCH3), 31.7 (C-1′′). 
 
6.2.4 Synthesis of (2-Allyl-3,6-dimethoxyphenyl)methanol 88 
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In a 250 cm3 two neck RB flask, allyl 2-allyl-3,6-dimethoxybenzoate (5.20 g, 20.0 mmol) 
was dissolved in THF (250 cm3). The solution was cooled to 0 °C and lithium aluminium 
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hydride (1.52 g, 40.0 mmol, 2 equiv.) was added slowly. The resulting suspension was 
heated to 40 °C and stirred for 2 h. The mixture was cooled to 0 °C again before a 10% 
aqueous hydrochloric acid solution (10%, 20 cm3) was slowly added. The aqueous layer 
was extracted with diethyl ether (4 × 50 cm3) and dichloromethane (3 × 50 cm3). The 
organic extracts were combined and dried with anhydrous MgSO4 before filtering 
through celite. The solvent was removed in vacuo and the residue was purified by silica 
gel column chromatography (20% EtOAc/hexane) to afford (2-allyl-3,6-
dimethoxyphenyl)methanol as a light yellow oil (3.89 g, 93%). Rf = 0.32 (20% 
EtOAc/hexane); IR (film): νmax(cm-1) = 3416 (s, br, OH), 1637 and 1598 (s, C=C); 1H 
NMR (300 MHz, CDCl3) δH = 6.77 (2H, dd, J=8.9, 4-H and 5-H), 6.04-5.91 (1H, m, 2′-
H), 5.00-4.88 (2H, m, 3′-H), 4.71 (2H, s, Ar-CH2-O), 3.83 (3H, s, OCH3), 3.78 (3H, s, 
OCH3), 3.54 (2H, d, J=5.8, 1′-H), 2.30 (1H, s, OH); 13C NMR (75 MHz, CDCl3) δC = 
152.3 (C-6), 151.8 (C-3), 137.4 (C-2′), 128.8 (C-1), 128.3 (C-2), 114.7 (C-3′), 110.7 (C-
4), 108.8 (C-5), 57.5 (OCH3), 56.3 (OCH3), 55.8 (Ar-CH2-O), 29.9 (C-1′). 
 
6.2.5 Synthesis of 2-Allyl-3-allyloxymethyl-1,4-dimethoxybenzene 87 
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In a 250 cm3 quick fit conical flask, fitted with a condenser, (2-allyl-3,6-
dimethoxyphenyl)methanol (2.70 g, 13.0 mmol) and allyl bromide (1.35 cm3, 1.88 g, 16.0 
mmol, 1.2 equiv.) were dissolved in dry THF (100 cm3). Sodium hydride (50-55% in oil, 
1.87 g, 39.0 mmol, ca. 3 equiv.) was added and the solution was refluxed for 24 h under a 
nitrogen atmosphere, while stirring. Workup was done by adding water (100 cm3) and 
then extracting the material with diethyl ether (4 × 50 cm3). The organic layers were 
combined, dried with anhydrous MgSO4, filtered through celite and the solvent removed 
CHAPTER 6  EXPERIMENTAL PROCEDURES 
85 
in vacuo. The residue was purified by silica gel column chromatography by using hexane 
as the initial eluent to remove the oil from the sodium hydride and then 20% 
EtOAc/hexane to afford 2-allyl-3-allyloxymethyl-1,4-dimethoxybenzene as a clear 
yellow oil (2.95 g, 91%). Rf = 0.59 (20% EtOAc/hexane); IR (film): νmax(cm-1) = 1638 
and 1595 (m C=C); 1H NMR (300 MHz, CDCl3) δH = 6.81 (1H, d, J=8.9, 6-H), 6.73 
(1H, d, J=8.9, 5-H), 6.03-5.89 (2H, m, 2′ and 2′′-H overlapped), 5.32-5.16 (2H, m, 3′′-
H), 4.96-4.89 (2H, m, 3′-H), 4.57 (2H, s, Ar-CH2-O), 4.03 (2H, d, J=5.8, 1′′-H), 3.78 
(3H, s, OCH3), 3.77 (3H, s, OCH3), 3.53 (2H, d, J=5.9, 1′-H); 13C NMR (75 MHz, 
CDCl3) δC = 152.9 (C-1), 151.6 (C-4), 137.1 (C-2′′), 135.4 (C-2′), 130.2 (C-3), 125.2 (C-
2), 116.9 (C-3′′), 114.4 (C-3′), 111.2 (C-6), 109.4 (C-5), 71.3 (C-1′′), 62.7 (Ar-CH2-O), 
56.4 (OCH3), 56.1 (OCH3), 30.3 (C-1′). 
 
6.2.6 Synthesis of 5,8-Dimethoxy-1H-isochromene 86 
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A 100 cm3 RB flask, equipped with a condenser, was set up under nitrogen. Neat 2-allyl-
3-allyloxymethyl-1,4-dimethoxybenzene (2.80 g, 11.3 mmol) was placed in the flask and 
the isomerisation catalyst, [RuClH(CO)(PPh3)3] (54 mg, 0.5 mol%) was added. The 
mixture was heated for 3 h at 90 °C. In this time the mixture went from light yellow to 
dark brown. Dry toluene (50 cm3) and the second generation Grubbs catalyst (48 mg, 0.5 
mol%) was then added to the flask and the solution cooled slightly to 70 °C and left at 
this temperature for 24 h. The material was dried onto silica while removing the solvent 
in vacuo. The material was then purified by silica gel column chromatography (5% 
EtOAc/hexane) to afford 5,8-dimethoxy-1H-isochromene as a yellow resin (1.85 g, 85%). 
Rf = 0.42 (5% EtOAc/hexane); IR (film): νmax(cm-1) = 1630 and 1581 (s, C=C); 1H NMR 
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(300MHz, CDCl3) δH = 6.66 (2H, dd, J=8.9, 6 and 7-H overlapped), 6.56 (1H, d, J=5.8, 
4-H), 6.04 (1H, d, J=5.8, 3-H), 5.11 (2H, s, Ar-CH2-O), 3.78 (3H, s, OCH3), 3.76 (3H, s, 
OCH3); 13C NMR (75 MHz, CDCl3) δC = 148.7 (ArC), 147.2 (ArC), 145.6 (C-4), 120.4 
(ArC), 116.9 (ArC), 110.1 (ArCH), 109.1 (ArCH), 99.4 (C-3), 62.7 (Ar-CH2-O), 56.0 
(OCH3), 55.7 (OCH3); HRMS: Found M+, 192.0797. C11H12O3 requires M 192.0786; m/z 
(EI) 192 (M+, 100%), 177 (78), 149 (16), 134 (7), 121 (10), 106 (5), 91 (10), 77 (10), 63 
(5). 
 
6.2.7 Synthesis of 5,8-Dimethoxy-isochroman-4-ol 85 
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In a 100 cm3 two neck RB flask equipped with a rubber septum under nitrogen, 5,8-
dimethoxy-1H-isochromene (1.2 g, 6.24 mmol) was dissolved in dry THF (50 cm3). The 
solution was cooled to 0 °C and a borane-methyl sulfide complex (2.0 M in Et2O, 3.75 
cm3, 7.49 mmol, 1.2 equiv.) was injected by syringe. The reaction mixture was stirred at 
this temperature for 30 mins, and then at rt for 2 h. The reaction mixture was cooled to 0 
°C again and aqueous sodium hydroxide (5 M, 6.24 cm3, 31.0 mmol, 5 equiv.) followed 
by aqueous hydrogen peroxide (30% w/w, 7.65 cm3, 75.0 mmol, 12 equiv.) were added 
rapidly. The clear solution turned cloudy and frothing was observed. The cloudy reaction 
mixture was stirred for 24 h before quenching with aqueous hydrochloric acid (5%, 150 
cm3). The organic material was then extracted with diethyl ether (4 × 80 cm3) and 
dichloromethane (4 × 80 cm3). The organic layers were combined, dried with anhydrous 
MgSO4, filtered through celite and the solvent then removed in vacuo. The residue was 
purified by silica gel column chromatography (50% EtOAc/hexane) to afford the 5,8-
dimethoxy-isochroman-4-ol as white flake-like crystals (1.10 g, 84%). Rf = 0.34 (50% 
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EtOAc/hexane); mp. 96-98 °C; IR (CHCl3): νmax(cm-1) = 3447 (w, br, OH), 1606 (s, 
C=C); 1H NMR (300MHz, CDCl3) δH = 6.72 (2H, m, 6 and 7-H overlapped), 4.85 (1H, 
d, J=16.0, 1-Ha), 4.79 (1H, m, 4-H), 4.51 (1H, d, J=16.0, 1-Hb), 4.08 (1H, dd, J=12.0, 
J=2.8, 3-Ha), 3.85 (3H, s, OCH3), 3.78 (1H, dd, J=12.0, J=3.1, 3-Hb), 3.76 (3H, s, 
OCH3), 2.88 (1H, s, OH); 13C NMR (75 MHz, CDCl3) δC = 151.5 (ArC-O), 149.2 (ArC-
O), 125.1 (ArC), 124.7 (ArC), 109.1 (ArCH), 108.3 (ArCH), 70.3 (C-3), 64.3 (C-1), 60.3 
(C-4), 55.7 (OCH3), 55.5 (OCH3); HRMS: Found M+, 210.0904. C11H14O4 requires M 
210.0892; m/z (EI) 210 (M+, 94%), 180 (100), 165 (49), 151 (7), 134 (9), 120 (10), 107 
(7), 91 (12), 77 (13), 65 (7), 51 (8). 
 
6.2.8 Synthesis of 5,8-Dimethoxy-3,4-dihydro-1H-isochromen-4-yl acetate 89 
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In a 100 cm3 2 neck RB flask, fitted with a rubber septum, 5,8-dimethoxy-isochroman-4-
ol (0.500 g, 2.38 mmol) was dissolved in dry THF (100 cm3). To this stirred solution was 
added a catalytic amount of 4-dimethylaminopyridine (DMAP), (29 mg, 0.48 mmol, 10 
mol%) followed by acetic anhydride (0.90 cm3, 19.0 mmol, 4 equiv.), and triethylamine 
(3.31 cm3, 47.7 mmol, 10 equiv.). The reaction mixture was stirred at rt for 3 h. The 
reaction was then quenched with water (50 cm3). The organic material was then extracted 
with EtOAc (4 × 80 cm3).  The organic layers were combined, dried with anhydrous 
MgSO4, filtered through celite and the solvent then removed in vacuo. The residue was 
purified by silica gel column chromatography (30% EtOAc/hexane) to afford the 5,8-
dimethoxy-3,4-dihydro-1H-isochromen-4-yl acetate as fluffy white crystals (0.42 g, 
70%). Rf  = 0.80 (50% EtOAc/hexane); mp. 119-121 °C; IR (CHCl3): νmax(cm-1) = 1729 
(s, C=O), 1646 (s, C=C), 1263 (s, C-O); 1H NMR (300MHz, CDCl3) δH = 6.79 (1H, d, 
J=8.9, 7-H)*, 6.72 (1H, d, J=8.9, 6-H)*, 5.93 (1H, m, 4-H), 4.83, (1H, d, J=16.1, 1-Ha), 
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4.48 (1H, d, J=16.1, 1-Hb), 4.23 (1H, dd, J=12.9, J=0.9, 3-Ha), 3.78 (3H, s, OCH3), 3.77 
(3H, s, OCH3), 3.73 (1H, dd, J=12.9, J=2.2, 3-Hb), 2.09 (3H, s, COCH3); 13C NMR (75 
MHz, CDCl3) δC = 170.6 (C=O), 151.9 (ArC-O), 149.0 (ArC-O), 126.2 (ArC), 120.0 
(ArC), 110.2 (ArC-H), 108.5 (ArC-H), 68.7 (C-3), 63.9 (C-1), 62.5 (C-4), 55.8 (OCH3), 
55.6 (OCH3), 21.2 (OC-CH3); HRMS: Found M+, 252.0999. C13H16O5 requires M 
252.0998; m/z (EI) 252 (M+, 29%), 192 (100), 177 (23), 149 (9), 134 (7), 105 (10), 91 
(10), 77 (7). 
(* interchangeable signals) 
 
6.2.9 General Procedure for the Synthesis of the Alcohol Substrates for Lipase 
Screening 
 
In a 250 cm3 RB flask, to a stirred solution of the ketone in methanol (10 cm3), was added 
soduim borohydride (1 equiv.). The reaction mixture was stirred for 2 h at rt. Work up 
was done by adding an aqueous 10% HCl solution (4 cm3). The organic product was 
extracted using EtOAc (3 × 10 cm3). The organic layers were combined, dried over 
anhydrous MgSO4, filtered and the solvent removed in vacuo. The product was purified 
by silica gel column chromatography (50% EtOAc/hexane) to yield the alcohol.  
 
6.2.9.1 The Synthesis of 1-(2,5-Dimethoxyphenyl) Ethanol 121 98 
 
OMe
OMe
OH
121
1
2
3
4
5
6 7
8OMe
OMe
O
170  
 
Clear oil (2.2 g, quantitative yield); Rf = 0.38 (30% EtOAc/hexane);  1H NMR (300 
MHz, CDCl3): δH = 6.94 (1H, d, J=2.8, 2-H), 6.76 (2H, td, J=5.8, J=8.9, 4-H and 5-H), 
5.06 (1H, q, J=6.4, 7-H), 3.81, (3H, s, OCH3), 3.77 (3H, s, OCH3), 2.73 (1H, s, OH), 1.48 
(3H, d, J=6.5, 8-H); 13C NMR (75 MHz, CDCl3) δC = 153.7 (Ar-CO), 150.6 (Ar-CO), 
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134.7 (Ar-C), 112.4 (Ar-CH), 112.3 (Ar-CH), 111.4 (Ar-CH), 66.3 (C-7), 55.7 (OCH3), 
55.7 (OCH3), 23.0 (C-8).  
 
6.2.9.2 The Synthesis of  5-Methoxy-1,2,3,4-tetrahydronaphthalen-1-ol 123 99 
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White solid (0.44 g, 87%); Rf = 0.42 (30% EtOAc/hexane); 1H NMR (300 MHz, CDCl3): 
δH = 7.18 (1H, t, J=7.8, 2-H), 7.05 (1H, d, J=7.6, Ar-CH), 6.75 (1H, d, J= 8.0, Ar-CH), 
4.75 (1H, s, OH), 3.81 (3H, s, OCH3), 2.75 (1H, td, J=5.0, J=8.9, 7-Ha), 2.54 (1H, td, 
J=6.4, J=13.5, 7-Hb), 1.84 (5H, m, 5-, 6- and 8-H);  
 
6.2.10 General Procedure for the Synthesis of the Acetate Substrates for Lipase 
Screening 
 
In a 25 cm3 two neck RB flask, fitted with a rubber septum, the alcohol was dissolved in 
dry THF (50 cm3). To this stirred solution was added a catalytic amount of 4-
dimethylaminopyridine (DMAP), followed by acetic anhydride (4 equiv.), and 
triethylamine (10 equiv.). The reaction mixture was stirred at rt for 3 h. The reaction was 
then quenched with water (25 cm3). The organic material was then extracted with EtOAc 
(4 × 50 cm3).  The organic layers were combined, dried with anhydrous MgSO4, filtered 
through celite and the solvent then removed in vacuo. The residue was purified by silica 
gel column chromatography (30% EtOAc/hexane) to afford the acetate. 
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6.2.10.1 The Synthesis of 1-Phenylethyl Acetate 124 100 
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Clear oil (1.07 g, 79%); Rf = 0.67 (30% EtOAc/hexane); 1H NMR (300 MHz, CDCl3): δH 
= 7.31 (5H, m, Ar-H), 5.88 (1H, q, J=6.6, 7-H), 2.07 (3H, s, COCH3), 1.53 (3H, d, J=6.6, 
8-H); 13C NMR (75 MHz, CDCl3) δC = 170.3 (COCH3), 141.7 (C-1), 128.5 (Ar-CH), 
127.8 (Ar-CH), 126.1 (Ar-CH), 72.3 (C-7), 22.2 (CH3), 21.3 (CH3). 
 
6.2.10.2 The Synthesis of 1-(2,5-Dimethoxyphenyl)ethyl Acetate 125 
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Clear oil (1.12 g, 91%); Rf = 0.53 (30% EtOAc/hexane); 1H NMR (300 MHz, CDCl3): δH 
= 6.94 (1H, d, J=2.6, 2-H), 6.77 (2H, m, 4-H and 5-H), 6.20 (1H, q, J=6.5, 7-H), 3.79 
(3H, s, OCH3), 3.77 (3H, s, OCH3), 2.08 (3H, s, COCH3), 1.46 (3H, d, J=6.5, 8-H); 13C 
NMR (75 MHz, CDCl3) δC = 170.0 (COCH3), 153.6 (Ar-C), 150.1 (Ar-C), 131.7 (Ar-C), 
112.4 (Ar-CH), 112.3 (Ar-CH), 111.6 (Ar-CH), 67.1 (C-7), 56.0 (OCH3), 55.6 (OCH3), 
21.2 (CH3), 21.2 (CH3). 
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6.2.10.3 The Synthesis of 1,2,3,4-Tetrahydronaphthalen-1-yl Acetate 126101 
OAc
126
2
1
3
4 5
6
7
8
OH
122  
 
Clear oil (1.11 g, 87%); Rf = 0.64 (30% EtOAc/hexane); 1H NMR (300 MHz, CDCl3): δH 
= 7.28-7.10 (4H, m, Ar-CH), 6.00 (1H, t. J=4.1, 8-H), 2.91-2.68 (2H, m, 7-H), 2.07 (3H, 
s, COCH3), 2.03-1.75 (4H, m, 5-H and 6-H); 13C NMR (75 MHz, CDCl3) δC = 170.7 
(COCH3), 137.8 (Ar-CH), 134.5 (Ar-CH), 129.3 (Ar-CH), 129.0 (Ar-CH), 128.0 (Ar-C), 
126.0 (Ar-C), 69.9 (C-8), 29.0 (CH2), 29.0 (CH2), 21.4 (COCH3), 18.7 (CH2). 
 
6.2.10.4 The Synthesis of 5-Methoxy-1,2,3,4-tetrahydronaphthlen-1-yl Acetate 
126 
 
OH
126
OAc
126
2
1
3
4 5
6
7
8
OMe OMe
 
 
Clear oil (0.22 g 89%); Rf = 0.62 (30% EtOAc/hexane); 1H NMR (300 MHz, CDCl3): δH 
= 6.23 (1H, t, J=7.9, 2-H), 6.89 (1H, d, J=7.8, Ar-CH), 6.77 (1H, d, J=8.1, Ar-CH), 5.97 
(1H, m, 8-H), 3.82 (3H, s, OCH3), 2.79-2.58 (1H, m, 7-Ha), 2.50-2.47 (1H, m, 7-Hb), 
2.07 (3H, s, COCH3), 1.97-1.84(4H, m, 6-H and 7-H); 13C NMR (75 MHz, CDCl3) δC = 
170.7 (COCH3), 160.0 (Ar-CO), 135.6 (Ar-C), 127.0 (Ar-C), 126.4 (Ar-CH), 121.3 (Ar-
CH), 109.1 (Ar-CH), 70.0 (CH2), 55.3 (OCH3), 28.5 (CH2), 22.7 (COCH3), 21.4 (C-8), 
18.0 (CH2). 
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6.2.11 Synthesis of (+)-5,8-Dimethoxy-isochroman-4-ol 85 
 
6 3
1
7
OMe
OMe
O
OH
(+)-85
or opposite
enantiomer
OMe
OMe
O
OAc
(-)-89
or opposite
enantiomer
6 3
1
7
OMe
OMe
O
OAc
89
 
 
To a stirred solution of the racemic 5,8-dimethoxy-3,4-dihydro-1H-isochromen-4-yl 
acetate (200 mg, 0.79 mmol) in toluene (5 cm3) was added a buffer solution of tris 
(hydroxymethyl)amino methane (40 cm3, 0.1 M, pH 7.5), followed by the lipase enzyme 
Novozyme 525 (40 cm3). The reaction mixture was allowed to stir at rt for 2 h. 
Completion of the reaction was determined by HPLC on a C18 column (70% acetonitrile 
in H2O), to show a 50% conversion of the racemic acetate to the alcohol. The reaction 
mixture was then extracted with EtOAc (3 × 80 cm3) to isolate the organic products. The 
organic layers were then combined and dried with anhydrous MgSO4, filtered through 
celite and the solvent removed in vacuo. The enantiomeric excess was determined by 
HPLC analysis in a Chiralcel OD column (200 × 46 mm) using 20% isopropyl alcohol in 
hexane as the mobile phase. The crude material was purified by silica gel column 
chromatography (30% EtOAc/hexane) to give the unreacted (−)-5,8-dimethoxy-3,4-
dihydro-1H-isochromen-4-yl acetate, [α]D = − 93.0 (c = 1 in CHCl3), (59 mg, 30% ) and 
the enantioselectively hydrolysed (+)-5,8-dimethoxy-isochroman-4-ol, [α]D = + 28.0 (c = 
1 in CHCl3), (54 mg, 33%). Both products were analysed spectroscopically and 
characterised as described above. 
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6.2.12 Synthesis of (−)-5,8-Dimethoxy-isochroman-4-ol 85 
 
6 3
1
7
OMe
OMe
O
OAc
(-)-89
or opposite
enantiomer
OMe
OMe
O
OH
(-)-85
or opposite
enantiomer  
 
In a 25 cm3 RB flask, to a stirred solution of the (−)-5,8-dimethoxy-3,4-dihydro-1H-
isochromen-4-yl acetate (20 mg, 0.079 mmol) in methanol (2 cm3), was added potassium 
carbonate (16.4 mg, 0.119 mmol, 1.5 equiv.). The reaction mixture was stirred for 2 h at 
rt. Work up was done by adding an aqueous 10% HCl solution (2 cm3). The organic 
product was extracted using EtOAc (3 × 5 cm3). The organic layers were combined, dried 
over anhydrous MgSO4, filtered and the solvent removed in vacuo. The product was 
purified by silica gel column chromatography (50% EtOAc/hexane) to yield the (−)- 
alcohol, (13.7 mg, 82%). Optical rotation [α]D = − 41.0 (c =1 in CHCl3). The product was 
characterised as described for the racemic alcohol. 
 
6.2.13 Synthesis (+)-5,8-Dimethoxy-3,4-dihydro-1H-isochromen-4-yl acetate 89 
 
6 3
1
7
OMe
OMe
O
OH
(+)-85
or opposite
enantiomer
OMe
OMe
O
OAc
(+)-89
or opposite
enantiomer  
 
In a 25 cm3 two neck RB flask, fitted with a rubber septum, (+)-5,8-dimethoxy-
isochroman-4-ol (13.0 mg, 0.062 mmol) was dissolved in dry THF (5 cm3). To this 
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stirred solution was added a catalytic amount of 4-dimethylaminopyridine (DMAP), (0.8 
mg, 0.006 mmol, 10 mol%) followed by acetic anhydride (0.023 cm3, 0.25 mmol, 4 
equiv.), and triethylamine (0.09 cm3, 0.62 mmol, 10 equiv.). The reaction mixture was 
stirred at rt for 3 h. The reaction was then quenched with water (5 cm3). The organic 
material was then extracted with EtOAc (4 × 10 cm3).  The organic layers were 
combined, dried with anhydrous MgSO4, filtered through celite and the solvent then 
removed in vacuo. The residue was purified by silica gel column chromatography (30% 
EtOAc/hexane) to afford the (+)-5,8-dimethoxy-3,4-dihydro-1H-isochromen-4-yl acetate 
as fluffy white crystals (12.7 mg, 81%). Optical rotation [α]D = +72.0 (c = 1 in CHCl3). 
The product was characterised as described for the racemic acetate. 
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6.3 Experimental Procedures Related to Part B 
 
6.3.1 Synthesis of 2-Iodo-1,3-dimethoxybenzene 120 
 
102
OMe
OMe
120
OMe
OMe
I
4
5
6
 
 
Into a flame dried 250 cm3 RB flask fitted dropping funnel was placed dry THF (50 cm3), 
followed by 1,3-dimethoxybenzene (4.74 cm3, 5.00 g, 36.2 mmol). The solution was 
cooled down to 0 °C. Once cooled, the n-butyllithium (1.4 M in hexane, 28.4 cm3, 39.8 
mmol, 1.1 equiv.) was slowly added using a dropping funnel. The solution was stirred at 
0 °C for 1 h. The dropping funnel was then charged with a solution of iodine (10.10 g, 
39.8 mmol, 1.1 equiv.) in THF (70 cm3). This solution was then added dropwise to the 
milky white reaction mixture. The end point of the reaction was observed at the 
appearance of the light brown halogen colour. The resulting solution was stirred for an 
additional 1 h at rt. Water was then added to the product mixture and the product 
extracted with CH2Cl2. The solvent was removed in vacuo and the crude product was 
recrystallised from dichloromethane-ethanol to give large white crystals of iodo-1,3-
dimethoxybenzene (8.84 g, 93%). Rf = 0.70 (30% EtOAc/hexane); mp.= 103-105 °C 
(lit102 104 °C); IR (CHCl3): νmax(cm-1) = 1587, 1470 (m, Ar C=C); 1H NMR (300 MHz, 
CDCl3): δH = 7.26 (1H, t, J=8.3, 5-H), 6.50 (2H, d, J=8.3, 6-H and 4-H), 3.89 (6H, s, 2 
×OCH3); 13C NMR (75 MHz, CDCl3) δC = 158.4 (2 × Ar C-O), 128.7 (C-5), 112.6 (ArC-
I), 104.5 (C-4 and C-6), 56.1 (2 × OCH3); HRMS: Found M+, 263.9654. C8H9IO2 
requires M 263.9647. m/z (EI) 264 (M+, 100%), 249 (6), 221 (18), 206 (7), 122 (8), 107 
(11), 92 (9), 77 (10),51 (8).  
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6.3.2 Synthesis of 2,2′,6,6′-Tetramethoxy-1,1′-biphenyl 103 
 
102
OMe
OMe
120
OMe
OMe
I
4
5
103
OMe
OMe
MeO
OMe
3
4'
3'
5'
 
 
Into a flame dried 250 cm3 RB flask fitted dropping funnel was placed dry THF (50 cm3), 
followed by 1,3-dimethoxybenzene (3.47 cm3, 3.66 g, 26.5 mmol, 1.1 equiv.). The 
solution was cooled down to 0 °C. Once cooled, n-butyllithium (1.6 M in hexane, 16.56 
cm3, 26.5 mmol, 1.1 equiv.) was slowly added using the dropping funnel. The solution 
was stirred at 0 °C for 1 h. Copper(I) iodide (5.05 g, 26.5 mmol, 1.1 equiv.), dried 
overnight in an oven at 110 °C, was added in portions, and the mixture was stirred at rt 
for another 2 h. The dropping funnel was then charged with a solution of 2-iodo-1,3-
dimethoxybenzene (6.36 g, 24.0 mmol) in dry pyridine (50 cm3). Once added, the 
dropping funnel was replaced with a condenser, and the mixture was heated under reflux 
for 72 h. The product mixture was then poured onto ice and acidified with concentrated 
aqueous HCl (ca. 25 cm3). The product was then extracted with CH2Cl2 (3 × 80 cm3). The 
organic extracted were then combined, dried with anhydrous MgSO4, and the solvent was 
removed in vacuo. The crude product was recrystallised from dichloromethane-ethanol to 
give 2,2′,6,6′-tetramethoxy-1,1′-biphenyl (6.12 g, 93%). Rf = 0.47 (30% EtOAc/hexane); 
mp.= 173-175 °C (lit78 175-176 °C); IR (CHCl3): νmax(cm-1) = 1587 (ArC=C); 1H NMR 
(300 MHz, CDCl3): δH = 7.28 (2H, t, J=8.3, 3-H and 3′-H), 6.65 (4H, d, J=8.3, 3-H, 3′-H, 
5-H and 5′-H), 3.71 (12H, s, 4 × OCH3); 13C NMR (75 MHz, CDCl3) δC = 158.4 (4 × 
ArC-O), 128.7 (C-4 and C-4′), 112.5 (C-1 and C-1′), 104.4 (C-3, C-3′, C-5 and C-5′), 
56.1 (4 × OCH3); HRMS: Found M+, 274.1198. C16H18O4 requires M 274.1205; m/z (EI) 
274 (M+, 100%), 243 (7), 228 (11), 155 (5), 151 (20), 114 (6), 91 (6). 
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6.3.3 Synthesis of 2,6-Dimethoxyphenylboronic acid 122 
 
102
OMe
OMe
122
OMe
OMe
B(OH)2
 
 
Into a flame dried 250 cm3 RB flask fitted dropping funnel was placed dry THF (100 
cm3), followed by 1,3-dimethoxybenzene (4.74 cm3, 5.00 g, 36.2 mmol). The solution 
was cooled down to 0 °C. Once cooled, the n-butyllithium (1.4 M in hexane, 31.1 cm3, 
43.4 mmol, 1.2 equiv.) was slowly added via the dropping funnel. The solution was 
stirred at 0 °C for 1 h. Trimethyl borate (16.22 cm3, 15.04 g, 144.7 mmol, 4 equiv.) was 
then added dropwise via a syringe, at 0 °C. the reaction was stirred for 18 h and allowed 
to warm up to rt. The mixture was then poured into a large beaker equipped with a stirrer 
bar. An equivalence of water was added and additional ether (50 cm3) the mixture was 
stirred vigorously and the initial pH checked to be basic. 1 M aqueous HCl was then 
added with stirring, and the pH checked after each addition. This was continued until the 
mixture was acidic. The organic layer was then extracted using diethyl ether ( 3 × 100 
cm3). The organic extracts were combined, washed with brine, dried with MgSO4 and 
filtered. The solution was then concentrated (ca. 20 cm3) by removing the solvent in 
vacuo. Hexane (ca. 100 cm3) was then added to this, resulting in the precipitation of the 
boronic acid. The solution was cooled in an ice bath and the crystals were then collected 
by filtration, and washed with cold hexane to afford 2-ethyl-6-methoxyphenylboronic 
acid (4.65 g, 71%). Rf = 0.27 (30% EtOAc/hexane); mp.= 92-96 °C (lit103 100-115 °C); 
IR (CHCl3): νmax(cm-1) = 3474 (br,s, OH), 1650, 1586 (ArC=C); 1H NMR (300 MHz, 
CDCl3): δH = 7.39 (1H, t, J=8.4, 4-H), 7.22 (2H, s, Ar-B(OH)2), 6.64 (2H, d, J=8.4, 5-H 
and 3-H), 3.91 (6H, s, 2 × OCH3); 13C NMR (75 MHz, CDCl3) δC = 165.4 (2 × ArC-O), 
132.9 (C-4), 104.4 (C-3 and C-5), 56.0 (2 × OCH3), 55.8 (ArC-B(OH)2); HRMS: Found 
M+, 182.0761. C8H11BO4 requires M 182.0750; m/z (EI) 182 (M+, 100%), 181 (26), 164 
(24), 138 (11), 109 (10), 78 (10), 76 (34). 
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6.3.4 Synthesis of 2,2′,6,6′-Tetramethoxy-1,1′-biphenyl 103 
 
120
OMe
OMe
I
4
5
103
OMe
OMe
MeO
OMe
3
4'
3'
5'122
OMe
OMe
B(OH)2
 
 
Into a two neck RB flask fitted with a dropping funnel and a condenser (oven dried and 
under argon) was placed Pd(PPh3)4 (0.87 g, 0757 mmol, 10 mol%) and 2,6-
dimethoxyphenylboronic acid (2.07 g, 11.36 mmol, 1.5 equiv.). The reaction vessel was 
degassed 5 times and refilled with argon gas. The dropping funnel was then charged with 
DME (21.0 cm3) and 2-iodo-1,3-dimethoxybenzene (2.0 g, 7.57 mmol). Argon gas was 
then bubbled into the dropping funnel by means of a Pasteur pipette and the solution was 
quickly added to the reaction flask. The dropping funnel was recharged with an aqueous 
Na2CO3 solution (1.8 M, 4.01 g, 21.0 cm3, 5 equiv.). This solution was similarly degassed 
for 10 mins and then discharged into the reaction vessel. The two phase mixture was 
heated to reflux and the yellow reaction mixture was left to reflux for 18 h. During this 
time the solution became homogenous as the catalyst fully dissolved and a colour change 
from yellow to pale brown occurred. The reaction mixture was cooled and decanted into 
a separating funnel. The flask was washed out with EtOAc (ca 100 cm3) and water (ca 
100 cm3). After thorough mixing, the organic phase was separated and the aqueous phase 
was extracted with EtOAc (3 × 80 cm3). The combined organic fractions were then 
washed with brine and dried over anhydrous MgSO4. After evaporation of the solvent in 
vacuo the crude material was purified by column chromatography (5 →10 →20% 
EtOAc/hexane) affording the desired 2,2′,6,6′-tetramethoxy-1,1′-biphenyl (1.41 g, 54%), 
as the unoptimised yield. The product was characterised as previously described in 
Section 6.3.2. 
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6.3.5 Synthesis of 2,2’,6,6’-Tetramethoxy[1,1′-biphenyl]-3,3′-dicarbaldehyde 104 
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Into a two neck RB flask under argon, fitted with a rubber septum, was added 2,2′,6,6′-
tetramethoxy-1,1′-biphenyl (0.70 g, 2.55 mmol) in dry CH2Cl2 (50 cm3). To this solution 
was added titanium tetrachloride (1.12 cm3, 1.93 g, 10.2 mmol, 4 equiv.) using a syringe 
through the septum. The solution immediately changed to an orange colour. The reaction 
mixture was then cooled down to −78 °C and dichloromethyl methyl ether (0.64 cm3, 
0.82 g, 7.14 mmol, 2.8 equiv.) was then added. The solution changed to a dark brown 
colour. Stirring at this temperature continued for 30 mins. The resulting solution was then 
warmed up to 0 °C over 1 h and stirred at this temperature for an additional 15 mins. The 
product mixture was then poured into a separating funnel containing crushed ice (ca 10 g) 
and aqueous conc. HCl (ca 8 cm3) and shaken vigourously. The organic layer was then 
separated, washed with water ( ca 50 cm3) and brine ( ca. 50 cm3). It was then dried over 
anhydrous MgSO4, filtered and the solvent removed in vacuo. The crude material was 
purified by silica gel column chromatography (40% EtOAc/hexane) to give 2,2’,6,6’-
tetramethoxy[1,1′-biphenyl]-3,3′-dicarbaldehyde as a white solid (0.80 g, 95%). Rf = 0.20 
(30% EtOAc/hexane); mp.= 151-155 °C; IR (CHCl3): νmax(cm-1) = 1673 and 1586 
(ArC=C); 1H NMR (300 MHz, CDCl3): δH = 10.17 (2H, s, 2 × ArCHO), 7.91 (2H, d, 
J=8.8, 4-H and 4′-H), 6.83 (2H, d, J=8.8, 5-H and 5′-H), 3.76 (6H, s, 2 × OCH3), 3.52 
(6H, s, 2 × OCH3); 13C NMR (75 MHz, CDCl3) δC = 188.8 (2 × ArCHO), 163.5 (2 × 
ArC-O), 162.7 (2 × ArC-O), 130.6 (2 × ArCH), 123.1 (2 × ArC-CHO), 116.4 (2 × ArC), 
107.1 (2 × ArCH), 63.0 (2 × OCH3), 56.1 (2 × OCH3); HRMS: Found M+, 330.1093. 
C18H18O6 requires M 330.1103; m/z (EI) 330 (M+, 79%), 299 (100), 283 (16), 255 (28), 
239 (66), 219 (17), 179 (28), 155 (10), 142 (9), 115 (10), 91 (5), 69 (19), 51 (5). 
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6.3.6 Synthesis of Diethyl [4,4′-diacetoxy-6,6′,8,8′-tetramethoxy-7,7′-binaphthalene]-
2,2′-dicarboxylate 105 
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H
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In a two neck RB flask, fitted with a condenser, under argon, 2,2’,6,6’-tetramethoxy[1,1′-
biphenyl]-3,3′-dicarbaldehyde (1.53 g, 4.63 mmol) and diethyl succinate (2.31 cm3, 2.42 
g, 13.9 mmol, 3 equiv.) were dissolved in dry t-butyl alcohol (20 cm3). To this mixture 
was slowly added potassium-t-butoxide (1.56 g, 13.9 mmol, 3 equiv.). The resulting 
solution was heated under reflux for 2 h and then allowed to cool down to rt, poured into 
a separatory funnel containing ice and acidified to pH 3 with aqueous conc. HCl. The 
product was then extracted with EtOAc ( 3 × 50 cm3). The combined organic extracts 
were then dried over anhydrous MgSO4, filtered, and the solvent removed in vacuo. The 
resultant oil was not purified or characterised, but used immediately in the next step. 
In a two neck RB flask, fitted with a condenser, under argon, the Stobbe condensation 
product from above was dissolved in acetic anhydride (80 cm3). To this was added 
anhydrous sodium acetate (1.89 g, 23.2 mmol, 5 equiv.). The mixture was heated at 140 
°C for 2 h and then allowed to cool. The acetic anhydride was removed in vacuo, water 
(ca 100 cm3) was added, and the product extracted with CH2Cl2 (3 × 100 cm3). The 
combined organic extracts were dried over anhydrous MgSO4, filtered and the solvent 
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removed in vacuo. The crude material was purified by silica gel column chromatography 
(30% EtOAc/hexane) to yield diethyl [4,4′-diacetoxy-6,6′,8,8′-tetramethoxy-7,7′-
binaphthalene]-2,2′-dicarboxylate 105 as a bright yellow solid (1.78 g, 60% over two 
steps). Rf = 0.17 (30% EtOAc/hexane); mp.= >180 °C; 1H NMR (300 MHz, CDCl3): δH 
= 8.77 (2H, s, 2 × ArCH), 7.87 (2H, s, 2 × ArCH), 7.01 (2H, s, 2 × ArCH), 4.43 (4H, q, 
J=7.1, 2 × OCH2CH3), 3.84 (6H, s, 2 × OCH3), 3.64 (6H, s, 2 × OCH3), 2.51 (6H, s, 2 × 
COCH3), 1.42 (6H, t, J=7.1, 2 × OCH2CH3); 13C NMR (75 MHz, CDCl3) δC = 169.4 (2 × 
CH3C=O), 166.2  (2 × Ar C=OOEt), 159.2 (2 × ArCOCH3), 156.5 (2 × ArCOCH3), 145.7 
(2 × ArC), 130.9 (2 × ArC), 125.2 (2 × ArC), 124.7 (2 × ArC), 123.9 (2 × ArCH), 118.9 
(2 × Ar CH), 117.8 (2 × ArC), 94.9 (2 × ArCH), 61.9 (2 × OCH3), 61.1 (2 × OCH2CH3), 
55.8 (2 × OCH3), 21.0 (2 × C=OCH3), 14.4 (2 × OCH2CH3); HRMS: Found M+, 
634.2038. C34H34O12 requires M 634.2050; m/z (EI) 634 (M+, 2%), 512 (32), 470 (27), 
428 (73), 382 (5), 54 (26), 43 (18). 
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APPENDIX  
 
A1: Selected 1H and 13C NMR Spectra Related to Part A 
 
A1.1.1 The 1H NMR Spectrum of Compound 107 
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A1.1.2 The 13C NMR Spectrum of Compound 107 
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A1.2.1 The 1H NMR Spectrum of Compound 88 
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A1.2.2 The 13C NMR Spectrum of Compound 88 
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A1.3.1 The 1H NMR Spectrum of Compound 86 
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A1.3.2 The 13C NMR Spectrum of Compound 86 
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A1.4.1 The 1H NMR Spectrum of Compound 89 
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A1.4.2 The 13C NMR Spectrum of Compound 89 
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A2: Selected 1H and 13C NMR Spectra Related to Part B 
 
A2.1.1 The 1H NMR Spectrum of Compound 120 
 
ppm (f1)
0.01.02.03.04.05.06.07.08.0
-10000
0
10000
20000
30000
40000
50000
60000
70000
80000
7.
28
5
7.
25
8
7.
23
0
6.
51
9
6.
49
2
3.
88
8
1.04
1.94
6.00
ppm (f1)
6.507.00
 
 
A2.1.2 The 13C NMR Spectrum of Compound 120 
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A2.2.1 The 1H NMR Spectrum of Compound 103 
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A2.2.2 The 13C NMR Spectrum of Compound 103 
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A2.3.1 The 1H NMR Spectrum of Compound 104 
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A2.3.2 The 13C NMR Spectrum of Compound 104 
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A2.4.1  1H NMR Spectrum of Compound 105 
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A2.4.2  13C NMR Spectrum of Compound 105 
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A3: Lipase Screening  
A3.1 Commercial Enzymes Utilized 
 
No. Supplier Enzyme (and abbreviation used)  Cat. No. 
A1 Biochemica Lipase, immobilised in Sol-Gel-AK from Candida antarctica (BiLCa) 62277 
A2 Biochemica Lipase from Mucor javanious (BLMj) 62304 
A3 Biochemica Lipase from Rhizopus niveus (BLRn) 62310 
A4 Biochemica Lipase from aspergillus (Bla) 84205 
A5 Biochemica Lipase from Penicillium roqueforti (BLPr) 62308 
A6  Control  
B1 Biochemica Lipase from Candida lipolytica (BLCl) 62303 
B2 Biochemica Lipase from Rhizopus arrhizus (BLRa) 62305 
B3 Biochemica Lipase from Pseudomonas flourescens (BLPf) 62312 
B4 Enzymes SA Lipase PS "Amano" (ESALPsA) LPSAW03506 
B5 Enzymes SA Lipase M "Amano" 10 (ESALMA10) LMW03503 
B6  Control  
C1 Enzymes SA Lipase F-APIS (ESALFA) LFW02523 
C2 Amano Lipase  (AKALAK) lot LAKA 0351202 
C3 Enzymes SA Lipase G "Amano" 50 (ESALGA50) LGDW01512 
C4 Amano Lipase AKC-I (ALAKC-I) lot ILAKY0452/02K 
C5 Enzymes SA Lipase AYS "Amano" (ESALAYSA) LAYW045145 
C6  Control  
D1 Biochemika Lipase from Aspergillus niger (BLAn) 62301 
D2 Biochemika Lipase from Candida antarctica (BLCa) 62299 
D3 Biochemika Lipase from Mucor miehei (BLMm) 62298 
D4 Altus Biologies Lipase-CR (ABLCR) lot: ACR-94-001 
D5 Biochemika Lipase from wheatgerm (BLW) 62306 
D6  Control  
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E1 Biochemika Lipase from Pseudomonas flourescens (BLPf) 71548 
E2 Amano Lipase AY "Amano" 30 (ALAYA30) LAYT02510 
E3 Biochemika Lipase from hog pancreas (BLHP) 62300 
E4 Biocatalysts Lipase - L056P (P. flourescens) (BcatLL056P0 1781981 
E5 Biocatalysts Candida cylindracea-L034 (BcatLCc) 1988784 
E6  Control  
F1 Biocatalysts Lipase L115P (BcatLL115P) 1768981 
F2 Biocatalysts Lipase L036P (BcatL036P) 1493971 
F3 Novozymes Novozym 435 Lipase (NL435) LC2 00015 
F4 Biochemika Lipase from Rhizopus oryzae (BLRo) 80612 
F5 Novozymes Lipozyme TL IM (NLTLIM) LA 35000504 
F6  Control  
G1 Enzymes SA Lipolase 100T (ESAL100T) LA 91231/10 
G2 Novozymes Lipozyme RM IM (NLRMIM) LUX 00111 
G3 Sigma Lipase (EC 3.1.1.3) Type II, Crude, from Porcine Pancreas (SLTIIPP) 
L3126 Lot 
70H0688 
G4 Novozymes Novozym 525 (NL525) LCN 01001 
G5 Enzymes SA SP 398 (ESASP398) LAN 00052 
G6  Control  
H1 Novozymes Novozym 388 (NL388) LUN 00020 
H2 Biochemika Esterase from Rhizopus oryzae (BERo) 79208 
H3 Biochemika Lipase from Pseudomonas cepacia (BLPc) 62309 
H4 Biochemika Esterase from horse liver (BEHL) 46069 
H5 Biochemika Esterase immobilized on Eupergit C from Hog liver (BiEHL) 46064 
H6  Control  
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A3.2 Lipase Kits 
 
Columns 1 to 6 in the following tables (1-5) contained the alcohol substrate with the acyl donor vinyl acetate and columns 7 to 12 
contained the acetate. Both reactions used the tris buffer system and IPA solvent. The positive results for the conversions are 
highlighted. 
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Table 1: Compounds 120 and 124 
 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A BiLCa BLMj BLRn Bla BLPr Control BiLCa BLMj BLRn Bla BLPr Control 
B BLCl BLRa BLCl ESALPsA ESALMA10 Control BLCl BLRa BLCl ESALPsA ESALMA10 Control 
C ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control 
D BLAn BLCa BLMm ABLCR BLW Control BLAn BLCa BLMm ABLCR BLW Control 
E BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control 
F BcatLL115P BcatL036P NL435 BLRo NLTLIM Control BcatLL115P BcatL036P NL435 BLRo NLTLIM Control 
G ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control 
H NL388 BERo BLPc BEHL BiEHL Control NL388 BERo BLPc BEHL BiEHL Control 
                          
 
Table 2: Compounds 121 and 125 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A BiLCa BLMj BLRn Bla BLPr Control BiLCa BLMj BLRn Bla BLPr Control 
B BLCl BLRa BLCl ESALPsA ESALMA10 Control BLCl BLRa BLCl ESALPsA ESALMA10 Control 
C ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control 
D BLAn BLCa BLMm ABLCR BLW Control BLAn BLCa BLMm ABLCR BLW Control 
E BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control 
F BcatLL115P BcatL036P NL435 BLRo NLTLIM Control BcatLL115P BcatL036P NL435 BLRo NLTLIM Control 
G ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control 
H NL388 BERo BLPc BEHL BiEHL Control NL388 BERo BLPc BEHL BiEHL Control 
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Table 3: Compounds 122 and 126 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A BiLCa BLMj BLRn Bla BLPr Control BiLCa BLMj BLRn Bla BLPr Control 
B BLCl BLRa BLCl ESALPsA ESALMA10 Control BLCl BLRa BLCl ESALPsA ESALMA10 Control 
C ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control 
D BLAn BLCa BLMm ABLCR BLW Control BLAn BLCa BLMm ABLCR BLW Control 
E BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control 
F BcatLL115P BcatL036P NL435 BLRo NLTLIM Control BcatLL115P BcatL036P NL435 BLRo NLTLIM Control 
G ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control 
H NL388 BERo BLPc BEHL BiEHL Control NL388 BERo BLPc BEHL BiEHL Control 
                          
 
Table 4: Compounds 123 and 127 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A BiLCa BLMj BLRn Bla BLPr Control BiLCa BLMj BLRn Bla BLPr Control 
B BLCl BLRa BLCl ESALPsA ESALMA10 Control BLCl BLRa BLCl ESALPsA ESALMA10 Control 
C ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control 
D BLAn BLCa BLMm ABLCR BLW Control BLAn BLCa BLMm ABLCR BLW Control 
E BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control 
F BcatLL115P BcatL036P NL435 BLRo NLTLIM Control BcatLL115P BcatL036P NL435 BLRo NLTLIM Control 
G ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control 
H NL388 BERo BLPc BEHL BiEHL Control NL388 BERo BLPc BEHL BiEHL Control 
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Table 5: Compounds 85 and 89 
 
  1 2 3 4 5 6 7 8 9 10 11 12 
A BiLCa BLMj BLRn Bla BLPr Control BiLCa BLMj BLRn Bla BLPr Control 
B BLCl BLRa BLCl ESALPsA ESALMA10 Control BLCl BLRa BLCl ESALPsA ESALMA10 Control 
C ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control ESALFA ALAK ESALGA50 ALAKC-I ESALAYSA Control 
D BLAn BLCa BLMm ABLCR BLW Control BLAn BLCa BLMm ABLCR BLW Control 
E BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control BLPf ALAYA30 BLHP BcatLL056P BcatLCc Control 
F BcatLL115P BcatL036P NL435 BLRo NLTLIM Control BcatLL115P BcatL036P NL435 BLRo NLTLIM Control 
G ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control ESAL100T NLRMIM SLTIIPP NL525 ESASP398 Control 
H NL388 BERo BLPc BEHL BiEHL Control NL388 BERo BLPc BEHL BiEHL Control 
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A4: Single Crystal Data and Structure for 2,2’,6,6’-Tetramethoxy[1,1′-biphenyl]-
3,3′-dicarbaldehyde 104 
 
OMe
OMe
MeO
OMe
H
O
H
O
104  
 
 
Table A4.1.  Crystal Data and Structure Refinement for 104 
 
Empirical formula  C18 H18 O6 
Formula weight  330.32 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 8.0686(13) Å   α= 90°. 
 b = 15.634(3) Å    β= 102.238(8)°. 
 c = 13.592(2) Å    γ = 90°. 
Volume 1675.5(5) Å3 
Z 4 
Density (calculated) 1.309 Mg/m3 
Absorption coefficient 0.099 mm-1 
F(000) 696 
Crystal size 0.43 x 0.18 x 0.18 mm3 
Theta range for data collection 2.01 to 27.99°. 
Index ranges -10<=h<=10, -16<=k<=20, -
17<=l<=17 
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Reflections collected 10745 
Independent reflections 4048 [R(int) = 0.0588] 
Completeness to theta = 27.99° 100.0%  
Absorption correction None 
Max. and min. transmission 0.9825 and 0.9588 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4048 / 0 / 221 
Goodness-of-fit on F2 0.974 
Final R indices [I>2sigma(I)] R1 = 0.0440, wR2 = 0.1133 
R indices (all data) R1 = 0.0795, wR2 = 0.1272 
Largest diff. peak and hole 0.211 and -0.224 e.Å-3 
 
Table A4.2.  Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for 104. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
 x y z U(eq) 
C(1) 1215(2) 2687(1) 4161(1) 29(1) 
C(1') 1820(2) 3591(1) 4189(1) 29(1) 
C(2) 2355(2) 2010(1) 4352(1) 31(1) 
C(2') 2463(2) 3937(1) 3403(1) 31(1) 
C(3) 1806(2) 1155(1) 4313(1) 36(1) 
C(3') 3107(2) 4777(1) 3458(1) 37(1) 
C(4') 3055(2) 5261(1) 4314(2) 45(1) 
C(4) 72(2) 1001(1) 4122(1) 40(1) 
C(5) -1103(2) 1652(1) 3947(1) 37(1) 
C(5') 2391(2) 4943(1) 5092(1) 43(1) 
C(6') 1778(2) 4104(1) 5034(1) 34(1) 
C(6) -532(2) 2496(1) 3937(1) 31(1) 
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C(7') 952(2) 3363(1) 1856(1) 48(1) 
C(7) 4820(2) 2258(1) 5607(1) 54(1) 
C(8') 3826(2) 5135(1) 2635(2) 51(1) 
C(8) 3030(3) 451(1) 4421(2) 52(1) 
C(9') 1200(2) 4161(1) 6702(1) 58(1) 
C(9) -3317(2) 3036(1) 3254(2) 51(1) 
O(1) 4069(1) 2186(1) 4551(1) 39(1) 
O(1') 2540(1) 3445(1) 2571(1) 39(1) 
O(2') 4459(2) 5841(1) 2648(1) 69(1) 
O(2) 2645(2) -305(1) 4383(1) 77(1) 
O(3') 1129(1) 3716(1) 5764(1) 44(1) 
O(3) -1574(1) 3183(1) 3710(1) 38(1) 
 
Table A4.3.   Bond lengths [Å] for 104. 
 
C(1)-C(2) 1.389(2) 
C(1)-C(6) 1.410(2) 
C(1)-C(1') 1.492(2) 
C(1')-C(2') 1.392(2) 
C(1')-C(6') 1.408(2) 
C(2)-O(1) 1.3795(18) 
C(2)-C(3) 1.406(2) 
C(2')-O(1') 1.3804(19) 
C(2')-C(3') 1.409(2) 
C(3)-C(4) 1.389(2) 
C(3)-C(8) 1.465(2) 
C(3')-C(4') 1.397(3) 
C(3')-C(8') 1.475(3) 
C(4')-C(5') 1.374(3) 
C(4')-H(4') 0.9500 
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C(4)-C(5) 1.376(2) 
C(4)-H(4) 0.9500 
C(5)-C(6) 1.399(2) 
C(5)-H(5) 0.9500 
C(5')-C(6') 1.399(2) 
C(5')-H(5') 0.9500 
C(6')-O(3') 1.3595(19) 
C(6)-O(3) 1.3588(18) 
C(7')-O(1') 1.440(2) 
C(7')-H(7'1) 0.9800 
C(7')-H(7'2) 0.9800 
C(7')-H(7'3) 0.9800 
C(7)-O(1) 1.439(2) 
C(7)-H(7A) 0.9800 
C(7)-H(7B) 0.9800 
C(7)-H(7C) 0.9800 
C(8')-O(2') 1.215(2) 
C(8')-H(8') 0.9500 
C(8)-O(2) 1.220(2) 
C(8)-H(8) 0.9500 
C(9')-O(3') 1.442(2) 
C(9')-H(9'1) 0.9800 
C(9')-H(9'2) 0.9800 
C(9')-H(9'3) 0.9800 
C(9)-O(3) 1.4304(19) 
C(9)-H(9A) 0.9800 
C(9)-H(9B) 0.9800 
C(9)-H(9C) 0.9800 
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Table A4.4.   Bond angles [°] for 104 
 
C(2)-C(1)-C(6)  118.10(13) 
C(2)-C(1)-C(1')  121.08(13) 
C(6)-C(1)-C(1')  120.83(13) 
C(2')-C(1')-C(6')  118.81(14) 
C(2')-C(1')-C(1)  121.46(13) 
C(6')-C(1')-C(1)  119.71(13) 
O(1)-C(2)-C(1)  118.77(13) 
O(1)-C(2)-C(3)  119.43(13) 
C(1)-C(2)-C(3)  121.77(14) 
O(1')-C(2')-C(1')  120.07(13) 
O(1')-C(2')-C(3')  118.88(14) 
C(1')-C(2')-C(3')  121.00(15) 
C(4)-C(3)-C(2)  117.92(14) 
C(4)-C(3)-C(8)  121.32(15) 
C(2)-C(3)-C(8)  120.68(15) 
C(4')-C(3')-C(2')  118.24(16) 
C(4')-C(3')-C(8')  120.88(16) 
C(2')-C(3')-C(8')  120.88(17) 
C(5')-C(4')-C(3')  122.09(15) 
C(5')-C(4')-H(4')  119.0 
C(3')-C(4')-H(4')  119.0 
C(5)-C(4)-C(3)  122.26(14) 
C(5)-C(4)-H(4)  118.9 
C(3)-C(4)-H(4)  118.9 
C(4)-C(5)-C(6)  118.90(15) 
C(4)-C(5)-H(5)  120.6 
C(6)-C(5)-H(5)  120.6 
C(4')-C(5')-C(6')  119.07(16) 
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C(4')-C(5')-H(5')  120.5 
C(6')-C(5')-H(5')  120.5 
O(3')-C(6')-C(5')  124.31(15) 
O(3')-C(6')-C(1')  114.92(13) 
C(5')-C(6')-C(1')  120.76(15) 
O(3)-C(6)-C(5)  123.99(13) 
O(3)-C(6)-C(1)  115.08(12) 
C(5)-C(6)-C(1)  120.92(14) 
O(1')-C(7')-H(7'1)  109.5 
O(1')-C(7')-H(7'2)  109.5 
H(7'1)-C(7')-H(7'2)  109.5 
O(1')-C(7')-H(7'3)  109.5 
H(7'1)-C(7')-H(7'3)  109.5 
H(7'2)-C(7')-H(7'3)  109.5 
O(1)-C(7)-H(7A)  109.5 
O(1)-C(7)-H(7B)  109.5 
H(7A)-C(7)-H(7B)  109.5 
O(1)-C(7)-H(7C)  109.5 
H(7A)-C(7)-H(7C)  109.5 
H(7B)-C(7)-H(7C)  109.5 
O(2')-C(8')-C(3')  124.4(2) 
O(2')-C(8')-H(8')  117.8 
C(3')-C(8')-H(8')  117.8 
O(2)-C(8)-C(3)  124.27(18) 
O(2)-C(8)-H(8)  117.9 
C(3)-C(8)-H(8)  117.9 
O(3')-C(9')-H(9'1)  109.5 
O(3')-C(9')-H(9'2)  109.5 
H(9'1)-C(9')-H(9'2)  109.5 
O(3')-C(9')-H(9'3)  109.5 
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H(9'1)-C(9')-H(9'3)  109.5 
H(9'2)-C(9')-H(9'3)  109.5 
O(3)-C(9)-H(9A)  109.5 
O(3)-C(9)-H(9B)  109.5 
H(9A)-C(9)-H(9B)  109.5 
O(3)-C(9)-H(9C)  109.5 
H(9A)-C(9)-H(9C)  109.5 
H(9B)-C(9)-H(9C)  109.5 
C(2)-O(1)-C(7)  113.87(13) 
C(2')-O(1')-C(7')  114.44(12) 
C(6')-O(3')-C(9')  118.78(14) 
C(6)-O(3)-C(9)  118.36(12) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  
Table A4.5.   Anisotropic displacement parameters (Å2x 103)for 104.  The 
anisotropic displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h 
k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
C(1) 31(1)  30(1) 24(1)  1(1) 3(1)  -3(1) 
C(1') 24(1)  27(1) 34(1)  -2(1) 2(1)  0(1) 
C(2) 31(1)  33(1) 27(1)  2(1) 2(1)  -2(1) 
C(2') 24(1)  29(1) 37(1)  3(1) 3(1)  4(1) 
C(3) 44(1)  31(1) 31(1)  4(1) 2(1)  -1(1) 
C(3') 25(1)  32(1) 51(1)  9(1) 2(1)  2(1) 
C(4') 33(1)  27(1) 68(1)  0(1) -5(1)  -3(1) 
C(4) 49(1)  31(1) 37(1)  2(1) 4(1)  -9(1) 
C(5) 35(1)  39(1) 35(1)  -1(1) 3(1)  -10(1) 
C(5') 36(1)  36(1) 50(1)  -15(1) -3(1)  1(1) 
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C(6') 26(1)  37(1) 36(1)  -3(1) 1(1)  0(1) 
C(6) 31(1)  33(1) 27(1)  -1(1) 4(1)  -2(1) 
C(7') 53(1)  53(1) 36(1)  -2(1) 6(1)  -3(1) 
C(7) 43(1)  59(1) 49(1)  -2(1) -11(1)  -6(1) 
C(8') 34(1)  48(1) 68(1)  26(1) 3(1)  -1(1) 
C(8) 54(1)  36(1) 60(1)  6(1) 0(1)  3(1) 
C(9') 44(1)  91(2) 38(1)  -22(1) 6(1)  0(1) 
C(9) 30(1)  53(1) 63(1)  -7(1) -3(1)  0(1) 
O(1) 31(1)  41(1) 42(1)  4(1) 0(1)  0(1) 
O(1') 38(1)  42(1) 37(1)  1(1) 11(1)  5(1) 
O(2') 47(1)  56(1) 96(1)  39(1) 0(1)  -11(1) 
O(2) 73(1)  33(1) 118(1)  9(1) 2(1)  4(1) 
O(3') 46(1)  52(1) 33(1)  -9(1) 10(1)  -4(1) 
O(3) 26(1)  37(1) 49(1)  -5(1) 2(1)  -1(1) 
 
 
Table A4.6.   Hydrogen coordinates ( x 104) and isotropic displacement parameters 
(Å2x 103) for 104. 
 
 x  y  z  U(eq) 
H(4') 3492 5827 4361 54 
H(4) -317 427 4113 48 
H(5) -2281 1530 3834 44 
H(5') 2350 5289 5661 51 
H(7'1) 85 3145 2199 72 
H(7'2) 1087 2964 1322 72 
H(7'3) 605 3923 1561 72 
H(7A) 4312 2742 5893 80 
H(7B) 6044 2351 5694 80 
H(7C) 4617 1730 5952 80 
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H(8') 3793 4789 2056 61 
H(8) 4199 592 4526 62 
H(9'1) 2386 4254 7036 87 
H(9'2) 638 3816 7139 87 
H(9'3) 622 4713 6569 87 
H(9A) -3393 2631 2696 76 
H(9B) -3853 3577 3000 76 
H(9C) -3900 2797 3756 76 
 
 
Table A4.7.  Torsion angles [°] for 104. 
 
C(2)-C(1)-C(1')-C(2') 76.56(19) 
C(6)-C(1)-C(1')-C(2') -103.17(17) 
C(2)-C(1)-C(1')-C(6') -102.07(17) 
C(6)-C(1)-C(1')-C(6') 78.21(19) 
C(6)-C(1)-C(2)-O(1) 178.61(13) 
C(1')-C(1)-C(2)-O(1) -1.1(2) 
C(6)-C(1)-C(2)-C(3) 0.8(2) 
C(1')-C(1)-C(2)-C(3) -178.94(14) 
C(6')-C(1')-C(2')-O(1') 179.13(12) 
C(1)-C(1')-C(2')-O(1') 0.5(2) 
C(6')-C(1')-C(2')-C(3') 1.8(2) 
C(1)-C(1')-C(2')-C(3') -176.88(13) 
O(1)-C(2)-C(3)-C(4) 179.24(14) 
C(1)-C(2)-C(3)-C(4) -3.0(2) 
O(1)-C(2)-C(3)-C(8) -3.7(2) 
C(1)-C(2)-C(3)-C(8) 174.05(15) 
O(1')-C(2')-C(3')-C(4') -178.57(13) 
C(1')-C(2')-C(3')-C(4') -1.2(2) 
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O(1')-C(2')-C(3')-C(8') 1.1(2) 
C(1')-C(2')-C(3')-C(8') 178.46(14) 
C(2')-C(3')-C(4')-C(5') -0.4(2) 
C(8')-C(3')-C(4')-C(5') 179.99(15) 
C(2)-C(3)-C(4)-C(5) 1.8(2) 
C(8)-C(3)-C(4)-C(5) -175.21(16) 
C(3)-C(4)-C(5)-C(6) 1.5(2) 
C(3')-C(4')-C(5')-C(6') 1.3(3) 
C(4')-C(5')-C(6')-O(3') 178.54(14) 
C(4')-C(5')-C(6')-C(1') -0.6(2) 
C(2')-C(1')-C(6')-O(3') 179.89(12) 
C(1)-C(1')-C(6')-O(3') -1.4(2) 
C(2')-C(1')-C(6')-C(5') -0.8(2) 
C(1)-C(1')-C(6')-C(5') 177.82(14) 
C(4)-C(5)-C(6)-O(3) 175.72(14) 
C(4)-C(5)-C(6)-C(1) -3.8(2) 
C(2)-C(1)-C(6)-O(3) -176.91(13) 
C(1')-C(1)-C(6)-O(3) 2.8(2) 
C(2)-C(1)-C(6)-C(5) 2.6(2) 
C(1')-C(1)-C(6)-C(5) -177.65(14) 
C(4')-C(3')-C(8')-O(2') 2.4(3) 
C(2')-C(3')-C(8')-O(2') -177.18(16) 
C(4)-C(3)-C(8)-O(2) -2.2(3) 
C(2)-C(3)-C(8)-O(2) -179.13(19) 
C(1)-C(2)-O(1)-C(7) 93.87(17) 
C(3)-C(2)-O(1)-C(7) -88.27(18) 
C(1')-C(2')-O(1')-C(7') 79.22(17) 
C(3')-C(2')-O(1')-C(7') -103.36(16) 
C(5')-C(6')-O(3')-C(9') -5.7(2) 
C(1')-C(6')-O(3')-C(9') 173.54(14) 
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C(5)-C(6)-O(3)-C(9) -13.6(2) 
C(1)-C(6)-O(3)-C(9) 165.94(14) 
 
Symmetry transformations used to generate equivalent atoms:  
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A4.8 ORTEP Diagrams of 104. 
 
 
